Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 Dec 20;19(12):e0302702. doi: 10.1371/journal.pone.0302702

Bovine milk consumption affects the transcriptome of porcine adipose stem cells: Do exosomes play any role?

Katherine Swanson 1, Jimmy Bell 2, David Hendrix 2, Duo Jiang 3, Michelle Kutzler 1, Brandon Batty 1, Melanie Hanlon 4, Massimo Bionaz 1,*
Editor: Wilfried A Kues5
PMCID: PMC11661651  PMID: 39705291

Abstract

The potential association of milk with childhood obesity has been widely debated and researched. Milk is known to contain many bioactive compounds as well as bovine exosomes rich in micro-RNA (miR) that can have effects on various cells, including stem cells. Among them, adipose stem cells (ASC) are particularly interesting due to their role in adipose tissue growth and, thus, obesity. The objective of this study was to evaluate the effect of milk consumption on miR present in circulating exosomes and the transcriptome of ASC in piglets. Piglets were supplemented for 11 weeks with 750 mL of whole milk (n = 6; M) or an isocaloric maltodextrin solution (n = 6; C). After euthanasia, ASC were isolated, quantified, and characterized. RNA was extracted from passage 1 ASC and sequenced. Exosomes were isolated and quantified from the milk and plasma of the pigs at 6–8 hours after milk consumption, and miRs were isolated from exosomes and sequenced. The transfer of exosomes from milk to porcine plasma was assessed by measuring bovine milk-specific miRs and mRNA in exosomes isolated from the plasma of 3 piglets during the first 6h after milk consumption. We observed a higher proportion of exosomes in the 80 nM diameter, enriched in milk, in M vs. C pigs. Over 500 genes were differentially expressed (DEG) in ASC isolated from M vs. C pigs. Bioinformatic analysis of DEG indicated an inhibition of the immune, neuronal, and endocrine systems and insulin-related pathways in ASC of milk-fed pigs compared with maltodextrin-fed pigs. Of the 900 identified miRs in porcine plasma exosomes, only 3 miRs were differentially abundant between the two groups and could target genes associated with neuronal functions. We could not detect exosomal miRs or mRNA transfer from milk to porcine-circulating plasma exosomes. Our data highlights the significant nutrigenomic role of milk consumption on ASC, a finding that does not appear to be attributed to miRs in bovine milk exosomes. The downregulation of insulin resistance and inflammatory-related pathways in the ASC of milk-fed pigs should be further explored in relation to milk and human health. In conclusion, the bioinformatic analyses and the absence of bovine exosomal miRs in porcine plasma suggest that miRs are not vertically transferred from milk exosomes.

Introduction

Obesity, especially childhood obesity, is a serious concern due to its links with cardiovascular disease, insulin resistance, and type II diabetes [1]. Adipose-derived stem cells (ASC) are mesenchymal stem cells that can differentiate into preadipocytes, osteocytes, chondrocytes, or myocytes [2]. Metabolic status and a difference in gene and hormone expression can determine which cell lineage these stem cells will commit to [2]. For preadipocytes, a metabolic environment characterized by a significant time of increased energy intake and increased glucose uptake appears to stimulate ASC differentiation [3]. This increase in adipogenic differentiation (or adipogenesis), along with the accumulation of lipid droplets in mature adipocytes (or lipogenesis), leads to obesity [3, 4].

While the cause of obesity can be related to various factors such as genetics, epigenetics, and environment, one of the most critical factors is diet [5, 6]. Nutritional factors such as protein and fat drive adiposity [7, 8]. Those nutritional factors are abundant in milk, the first food humans consume, and many humans continue to consume milk throughout their lives. It has been argued that proteins in milk can increase the activation of the Mammalian Target of Rapamycin Complex 1 (mTORC1) pathway that, in turn, can upregulate lipogenesis [7] in adipocytes, leading to an increase in obesity. This does not appear to be supported by clinical studies where data indicated that drinking whole cow’s milk at a young age reduced the risk of children developing obesity [8, 9]. Due to the limitations associated with clinical studies, conclusive proof of whether or not milk directly affects adipogenesis and lipogenesis, and in turn obesity, is lacking and, if so, the mechanism behind this effect.

In addition to the concern regarding milk and obesity, there has been more focus on the role sugary beverages might play. Researchers have found an association between increased consumption of sugary beverages and obesity [10]. Similar studies have been conducted to assess the correlation between milk consumption and sugary beverages on obesity in children [11, 12]. These studies found that consuming milk was correlated to an increase in lean body mass in contrast to the correlation between consumption of sugary beverages and an increase in obesity [11, 12]. None of these studies could directly prove the effect of milk or sugary drinks on the incidence of obesity.

Milk is a complex nutritional product containing many bioactive molecules [13]. One of the bioactive molecules discovered in milk are micro RNAs (miRs) in exosomes. miRs are small RNAs that suppress the expression of specific target genes through post-transcriptional silencing [14]. Exosomes are microvesicles that are around 100 nm in diameter that work as cargo vesicles for several oligonucleotide molecules between cells, including miRs [15]. Various studies have provided evidence that these exosomal miRs are stable under degradative conditions and can be taken up by the cells of non-origin species in vitro [16, 17] and can be absorbed from milk in the gastrointestinal tract (i.e., vertically transferred) [17, 18]. Milk exosomes are enriched with miRs that target genes associated with the immune response [19]; however, bovine milk exosomes also contain miRs that can target genes related to adipogenesis, such as miR200c or miR-21 [20, 21]. Therefore, miRs in bovine milk exosomes may be transferred to humans consuming that milk, affecting adipogenesis.

To our knowledge, there are no in vivo studies investigating the effect of bovine milk on ASC. primarily via an impact on the transcriptome by changes in plasma miRs profile after consuming the milk. Given the presence of adipogenesis-related miRs in bovine milk, our study aimed to explore the possibility of these miRs being vertically transferred from plasma to circulation and, ultimately, ASC in the animals consuming milk. Using growing piglets as our model for young children [22], we sought to determine whether the oral consumption of bovine milk compared to an isocaloric maltodextrin supplementation could affect the quantity of ASC in adipose tissue and their adipogenesis/lipogenesis capacity and transcriptome. In addition, we aimed to determine if consumption of bovine milk affects the profile of miRs present in plasma exosomes that might, in turn, affect ASC adipogenesis/lipogenesis. We hypothesized that milk consumption compared to isocaloric maltodextrin supplementation affects the adipogenic capacity of ASC via changing the miRs profile of circulating exosomes that, in turn, affect ASC transcriptome.

Methods

Animals and experimental design

Experimental procedures used in this study were approved by the Institutional Animal Care and Use Committees of Oregon State University (protocol #4691). The in vivo experiment was conducted between January and March of 2017.

Details of the animals used, and experimental design were previously described (see Study 2 in [23]). Twelve Duroc-Berkshire male piglets 8–9 weeks of age were randomly assigned to groups blocking for weight and litter for an 11-week trial. The piglets were kept in the Hogg Animal Metabolism Barn at Oregon State University in 1.3 m2 pens with the ground lined with AstroTurf. The room had an air conditioner system, and the temperature was maintained at 20°C. All pigs had unlimited access to water and were fed every morning, as previously described [23]. In addition to the feed, the piglets received an additional isocaloric supplement of either a maltodextrin solution (C; cat# 007-345-0341, Honeyville, USA) or whole fresh raw cow milk collected daily from the Oregon State University Dairy bulk tank (M). The milk samples collected over three days during the experiment were used for exosome isolation (see below). The maltodextrin solution was made every 3–4 days and kept refrigerated when not being fed. Milk was fed at 750 mL/d (4.8% fat, 3.6% protein, 4.8% lactose) while maltodextrin solution at 500 mL/d. The maltodextrin solution amount was calculated based on the number of calories in the milk (576.3 kcal in 750 mL), given that maltodextrin has an energy density of 4 kcal/g. Each piglet received 144 g of maltodextrin mixed in 500 mL of water to make it a palatable consistency. The supplements were fed in small troughs separate from their feed troughs, and the piglets were given their food after they drank their supplement, usually within 1–2 minutes.

On the last day of the study, blood was drawn from the jugular of each piglet using 22G 3.5” hypodermic needles (cat# N22312, Air-Tite Vet, Virginia Beach, VA) into 10 mL heparin tubes at 6 hours after the supplements were fed. The heparin tubes were centrifuged at 3000×g for 10 minutes to separate the plasma for exosome and miRs isolation. At the end of the 11 weeks, the piglets were euthanized via a jugular injection of euthasol (Somnasol Euthanasia, cat# EU-HS-045-100-0, HenrySchein, USA).

Exosome isolation from porcine plasma and bovine milk

For both the pig serum and bovine milk, exoRNeasy Serum/Plasma Midi Kits (cat# 77044) or exoEasy Maxi Kits (cat# 76064) from Qiagen (Germany) were used to isolate exosomes and extract miRs from the exosomes, respectively. To ensure the milk was free of milk fat globules, cells, and cellular debris, it was first poured into a 50 mL conical tube (cat# 89039–656, VWR, USA) and centrifuged at 3000×g for 10 minutes at room temperature to allow the top cream layer to be removed with a metal spatula. Then, it was poured into a new 50 mL conical tube and centrifuged again at 3000×g for 10 minutes to remove the rest of the cream. Then, 5 mL of the supernatant was transferred into a new ultracentrifuge tube. These tubes were centrifuged at 12000×g for 1 hour in a JA-20.1 fixed angle rotor in a Beckman Coulter Optima L-100K ultracentrifuge. The tubes were transferred to a 50 TI rotor and centrifuged for 1 hour at 35000×g. Using the same rotor, the tubes were centrifuged for 1 hour at 70000×g. Then, the clear supernatant was transferred to a new sterile 15 mL tube (cat# 89039–664, VWR, Radnor, PA) for exosome and miR isolation. After ultracentrifugation, the exosomes from the bovine milk were isolated using the same protocol to isolate exosomes from the blood plasma. Samples were filtered using a 0.8 μm syringe filter (Millipore Millex-AA SLAA033SB) into a new 15 mL tube. The isolation of exosomes was performed following the manufacturer’s instructions. For the samples used for only exosome isolation, 1mL of buffer XE was added to the spin column and centrifuged at 2000×g for 5 minutes to elute the exosomes. The flow through was reapplied to the spin column and centrifuged at 4300×g for 5 minutes. The eluted exosomes were stored at -20°C for further analysis. Exosomes were quantified, and particle size distribution was analyzed using ZetaView (Particle Matrix, Germany).

To isolate miRs, the spin column containing purified exosomes was transferred to a new collection tube, and 700 μl of QIAzol was added to the column before it was centrifuged at 4,300×g for 5 minutes. The isolation of RNA was performed following the manufacturer’s protocol. The samples in RNase-free water were then stored at -80°C until further analysis.

Exosome marker confirmation

Isolated exomes were confirmed using the Exo-Check antibody array kit (cat# EXORAY200B-4, Cat #EXORAY210B-8) from System Biosciences (Palo Alto, CA) that checks for exosome markers CD63, CD81, ALIX, FLOT1, ICAM1, EpCam, ANXA5 and TSG101. Previously isolated exosomes stored at -80°C were used for this assay. The exosomes were stored in 1X PBS and confirmation of exosome markers was performed following the manufacturer’s protocol. The developed membrane was imaged using luminescence capture in a MultiImage II, Alpha Innotech.

Adipose stem cell isolation

Once the piglets were euthanized, subcutaneous back fat from each piglet was dissected using a sterile procedure. The corps of the animals were hung with their heads down and bled by severing both jugular veins. The area encompassing the back, loin, and rump was clipped, followed by sterile gauze immersed in Povidone scrub (cat#3659, HenrySchein, USA) to clean the area. Then, a sterile gauze immersed in 70% ethanol was used to complete the cleaning of the area. The procedure was repeated once, and 70% ethanol was sprayed on the whole area that was to be collected. A butcher knife was cleaned using Povidone scrub followed by 70% ethanol, and the entire area, including the skin and the subcutaneous fat, was dissected. The tissue was then “closed as a book,” ensuring the sterile backfat was internal and the skin was external. The whole dissected tissue was put in a large, fresh Ziploc bag and stored on ice for 4 hours before beginning the stem cell isolation. The ASC were isolated as previously described [24]. Briefly, a sterile layer of fat was separated and weighed in pre-weighed sterile petri dishes (cat# 32-107G, Genesee Scientific, USA) before being minced using a sterile scalpel blade and digested for 45 min in a shaker in 0.075% collagenase (Collagenase Type I, Clostridium histolyticum; cat# J62406, Alfa Aesar, USA) at 37°C. The resulting cells were then passed through a 70 μM cell strained (cat# 10199–656, VWR, USA), red blood cells lysed using a red lysis buffer (cat# 89131–000, VWR, USA), and cells collected in 20 ml DMEM (cat# 25–500, Dulbecco’s Modified Eagle’s Medium, Gen Clone, USA) containing 10% FBS (cat# S11150, Atlanta Biologicals, USA), 10000 U/mL of PennStrep (cat# 25–512, Gen Clone, USA), and 3% amphotericin (cat# ABL01-100ML, Caisson, USA). The tubes containing the cells in DMEM were centrifuged at 400×g for 5 minutes, followed by resuspension of the cell pellet in 10 mL of DMEM.

To count viable nucleated cells, 75 μL of isolated cells in media was added to 75 μL of a staining solution containing one drop of NucBlue™ Live ReadyProbes™ Reagent (cat#R37605, ThermoFisher Scientific, USA) and one drop of NucRed™ Dead 647 ReadyProbes™ Reagent (cat#R37113, ThermoFisher Scientific, USA) in 500 μL PBS. Cells were incubated in the staining solution for 15 minutes before loading the cells into both counting chambers of a hemocytometer. Pictures for each of the 8eightcounting quadrant areas of the hematocytometer were taken using the DAPI and the Y55 (far red) filters in a robotic fluorescence microscope (Leica DMI6000B, Leica Microsystems, USA). The number of live cells were counted using CellProfiler [25]. Cells were then plated at 10000 viable cells per cm2 in two 75 cm2 flasks (cat# 10062–860, VWR, USA). The cells were placed in a humidified incubator and maintained at 39°C with 5% CO2, and the first media was changed after 24 hours. The remaining cells (i.e., passage 0) were immersed in 1 mL freezing media (cat# SH30894.01, HyClone™ AdvanceSTEM Cryopreservation Medium, GE Healthcare, USA), left at -80°C overnight, and stored in liquid N.

Colony forming unit (CFU) assay

The CFU was performed as previously described [24]. Briefly, harvested ASC were plated at a density of 25000 cells/25 cm2 culture flask (cat# 82051–074, VWR, USA) with three technical replicates. After plating, the cells were incubated at 39°C and 5% CO2, with the first media change 24h later and subsequent media changes occurring every 72 hours. After 14 days of culture, colonies were fixed using 10% buffered formalin (cat# CA71007-348, VWR, USA) for 30 minutes, exposed to hematoxylin staining solution (cat# 3536–32, RICCA Chemical Company, USA) for 30 min, and washed with tap water. The stained colonies were then manually counted.

Proliferation assay

To assess the growth of the ASC, the Vybrant MTT Cell Proliferation Assay was used (cat# V13154, Molecular Probes Inc). To ensure consistent density of cells between groups plated for this assay, passage one cells were used. The primary ASC were passed as previously described [24]. Briefly, the passage 0 ASC were harvested using 0.25% trypsin (cat# 02-0154-0100, VWR, USA) before being centrifuged at 1000×g and re-suspended in DMEM. The cells were then counted using a hematocytometer and plated at a 10000 cells/well density in two 96-well flat bottom plates with three technical replicates per animal. After 24 hours, one plate was used to count the number of attached cells using NucBlue™ Live ReadyProbes™ Reagent to account for any discrepancies in original number of cells plated. After 72 hours, the second plate was used with the Vybrant MTT Cell Proliferation Assay kit following the manufacturer’s protocol. Briefly, MTT stock solution was added to the cells in fresh media, which were then incubated at 39°C for 4 hours to label the cells. Then, DMSO was added to solubilize the formazan before reading the absorbance at 540 nm. Previously isolated porcine ASC plated at different known concentrations were used to make a standard curve to calculate the final amount of ASC/well. These values were then divided by the amounts counted at 24 hours and multiplied by 100 to give the percentage of proliferation over 48 hours.

In vitro adipogenic and osteogenic differentiation

For differentiation, passage 1 ASC were plated in 48 well plates at a density of 40000 cells/well. Four plates were used for each differentiation assay to allow for the separate analysis of four time points: 0, 7, 14, and 21 days. The ASC from each pig were plated simultaneously, and the differentiation media was added at 80% confluence for the osteogenic assay and 90% confluence for the adipogenic assay. Osteogenic and adipogenic media were prepared as previously described [24] with the adipogenic media containing one μM dexamethasone (cat#50-02-2, Alfa Aesar, USA), 0.5 mM 3-isobutyl-1-methylxanthine (cat# 28822-58-4, Acros Organics, USA), 200 μM indomethacin (cat# 53-86-1, Alfa Aesar, USA), and 0.5 μg/mL porcine insulin (cat # 12584-58-6, Sigma-Aldrich, USA). The osteogenic media was prepared to contain 0.1 μM dexamethasone, 10 mM ß-glycerophosphate (cat# A2253-0100, AppliChem, USA), and 50 μM ascorbic acid (cat# 50-81-7, G-Biosciences, USA). At each time point, cells from both assays were fixed by rinsing with DPBS before adding 10% buffered formalin for 30 minutes; at this point, the formalin was removed.

For adipogenic cells, the fluorescent Nile Red stain was used (cat# 22190, AAT Bioquest Inc., USA). Briefly, a 500 nM working solution was made by adding 2.38 μL of 10.5 mM stock solution to 50 mL DMEM. In addition, 100 drops of NucBlue nuclear stain were added to 50 mL DMEM to stain the nuclei of the cells. This working solution was then added to the fixed cells. The plates were incubated at room temperature for 12 min before removing the working solution and adding DPBS. The wells were then viewed using a robotic fluorescence microscope (Leica DMI6000B) to take nine pictures of each well using both a DAPI (blue) and N2.1 (red) filter to view both the nuclei and lipid droplets of each cell. These pictures were then analyzed using CellProfiler 3.0.0 to count the number of adipocytes, total cells, and lipid droplets/cell. The CellProfiler pipeline is available in S1 File.

For osteogenic cells, the Alizarin Red S stain (cat# 130-22-3, Amresco, USA) was used following a previously described protocol [24]. Osteogenic cells were viewed using the bright field setting of the microscope (Leica DMI6000B). The osteogenic assay was performed only to confirm the presence of typical osteogenic nodule formation [24] by mesenchymal stem cells. For this reason, osteogenesis was not quantified.

RNA isolation

For the isolation of RNA from ASC, passage 1 cells were plated at 10000 cells/well, grown to 80% confluence (8–14 days), and harvested using 0.25% trypsin before being homogenized and stored in 1 mL TRIzol (cat# 15596026, ThermoFisher) in microcentrifuge tubes (cat# 22–281, Genesee Scientific, USA) at -80°C. Total RNA was isolated using a previously described method [26] and cleaned using RNeasy Mini Kit (cat# 74104, QIAGEN, Germany) following the manufacturer’s instruction (without DNA digestion). The RNA was eluted using 40 μl of RNase free water and stored at -80°C until further analysis.

RNA sequencing and analysis

The RNA samples were sent to the Center for Genomic Research and Biocomputing (now Center for Quantitative Life Sciences) at Oregon State University to be sequenced. The samples were run on the Illumina HiSeq 3000 as 150 bp paired-end runs (Illumina, USA). The RNAseq files were then aligned and annotated using Kallisto [27]. A Kallisto index file was created using a known transcriptome for Sus scrofa from NCBI (GCF_000003025.6_Sscrofa11.1_rna.fna, NCBI). Then, each pair of samples paired-end reads files were pseudo-aligned to the index file using default options in Kallisto, and 100 bootstraps were used for each run. The bootstrapping allows for repeat analysis with replacement to help account for technical variance and get rough confidence intervals. The resulting annotated RNA count estimates were used for the statistical analysis.

miRs sequencing and analysis

The porcine plasma exosome miRs and bovine milk exosome miRs were sent to the Center for Genomic Research and Biocomputing (now Center for Quantitative Life Sciences) at Oregon State University to be sequenced. The samples were run on the Illumina MiSeq 3000 as small RNA reads. The adapter sequences from the resulting read files were trimmed using cutadapt [28] with options set to trim each sequence at locations with less than a 20% mismatch from the original adapter sequence and to trim low-quality ends that did not meet a minimum quality score cutoff of 10. Trimmed read sequences were mapped to locations within their respective genomes using bowtie [29] with a seed length 22 and returning alignments with 2 or fewer mismatches. Reads were aligned to the Sscrofa11.1 genome for pig samples and the UMD3.1.1 genome for cow milk samples. After the reads were mapped, they were annotated using miRBase v21 [30]. Homologous and novel miRs were found using miRWoods [31]. The sequence alignments used in miRWoods predictions were produced according to the miRWoods manual and had slightly different settings for cutadapt and bowtie. Trimmed reads from cutadapt were suppressed if they were less than 17 nucleotides in length, and a script from the miRwoods package was run to remove trimmed reads with average quality scores of less than 30. Bowtie was run with settings that searched for alignment within a seed length of 18, a maximum mismatch quality score of 50, and only reported alignments from the best stratum of alignments with 10 or fewer mappings to the genome.

Milk miRs transfer to porcine plasma

Three 5-week-old Yorkshire Hampshire piglets (11.1±0.19 kg) were enrolled, and whole fresh milk from the bulk tank of the Oregon State University Dairy Farm was used. The piglets were kept in a single pen during the 4-day adaptation period, where an increased amount of milk was provided in a single plastic feeder (S1 Fig in S2 File). After the piglets could completely drink 1.2 L in <20 min as a group, they were separated into single pens. There a second 2-day adaptation period was performed before starting the trial. On the first day, 400 mL and 500 mL of milk were provided at 9:00 AM on the second day. The time for the complete consumption of milk was recorded. All animals could consume ≥400 mL of milk in <6 min during the second day. For this reason, the study was started after six days of adaptation by providing 700 mL of milk to each animal at 9:00 AM. Blood was collected as described above at time 0 (i.e., just before giving the milk) and then at 1, 2, 4, and 6 hours after providing the milk. The time of blood collection was based on a similar prior study performed in humans [17]. Milk that still needed to be consumed was measured at each blood collection to determine the rate of milk consumption. Pig chow was provided to the piglets once most of the milk was consumed. As described above, the milk exosomes and the RNA in the exosomes were isolated from a sample of the milk fed to the piglets and from the plasma samples. Primers to amplify specific miRs were designed and ordered via QIAGEN. cDNA from the isolated RNA was performed using miScript II RT kit (cat# 218160, QIAGEN) following the manufacturer’s instruction. Briefly, for a 20 μL total reaction per sample, a total of 60 ng of RNA was used with 4 μL of the 5x miScript HiSpec buffer, 2 μL of 10x miScript Nucleics Mix, 2 μL of miScript Reverse Transcriptase mix, and brought to 20 μL volume using RNase/DNase free water. Following the manufacturer’s guidelines, the PCR reaction was performed using the miScript SYBR Green PCR Kit (cat#218073, QIAGEN). Briefly, a 10 μL reaction was performed in triplicate with 3 μL cDNA (diluted 4-fold using RNase/DNase free water), 5 μL SYBR green, 1 μL of both 10x miScript Universal Primer and 10x miScript Primer. The primers to amplify Sus scrofa Let7b, miR1285, miR148A, miR200a, miR200c, miR22, and miR29b were designed and produced via QIAGEN custom miScript Primer Assay. Two bovine transcripts (CSN3 and LALBA) plus porcine GAPDH were also measured in the plasma exosomes from pigs. RTqPCR methods and primers were as previously described [26, 32]. Both PCR assays were performed using an ABI 7900HT system with 40 cycles, and the final data was obtained using LinRegPCR [33].

Statistical analysis

All data, except RNA sequencing data, was analyzed using SAS (v9.4, SAS Institute, USA). Data was checked for outliers using Prog Reg. Data with studentized t≥3 were removed for subsequent statistical analysis. Datasets without a time component were analyzed using a Proc GLM with treatment as the main effect and pig as the random effect. For the exosome size, GLM analysis was performed in each separate bin. For adipogenesis-related data, a GLIMMIX model was used with a heterogenous autoregressive covariate model (chosen after checking for the smaller Akaike Information Criterion and the Generalized Chi-Square/degree of freedom ratio close to 1). A p-value of ≤0.05 denotes a biologically significant effect, while p-values >0.05 and ≤0.1 denote a trend.

A negative binomial model was fitted to the data using the edgeR package in R for mRNA and miR transcriptomes. The resulting output included transcripts differentially expressed (DEG) amongst the treatment group compared to the control group, associated p-values, and false discovery rate (FDR).

Functional analysis of differentially expressed RNA

For mRNA transcriptome, only transcripts with an FDR < 0.1 were further analyzed using the Dynamic Impact Approach (DIA) [33] and the Database for Annotation, Visualization, and Integrated Discovery (DAVID) v6.8 [34]. For DIA, the Sus scrofa gene IDs were converted to Homo sapiens gene IDs by using the biological DataBase network (https://biodbnet-abcc.ncifcrf.gov/) [35]. The annotated transcriptome (i.e., all transcripts detected in ASC) was used as the background for DIA and DAVID. Results from DAVID were downloaded using the “cluster” and “chart” options.

For miRs with a significant difference in abundance in plasma exosomes between groups, downstream target genes were predicted using TargetScanHuman, v. 7.2 [36]. Functional enrichment analysis of the target genes was performed by DAVID using the whole human transcriptome as background, considering all predicted targets and, to minimize false positives, also predicted target with a cumulative weighted context++ score of ≤-0.4. Enrichment of miRs in the DEG in ASC isolated from piglets supplemented with milk vs. the ASC isolated from piglets supplemented with maltodextrin was performed using MIENTURNET [37].

Effects of milk-specific miRs on ASC using gene reporters

To assess the activity of milk-specific miRs on ASC as previously performed [17], reporter gene plasmid for miR-29b and miR-200c were generously provided by Dr. Janos Zempleni (University of Nebraska–Lincoln). However, due to the known poor transfection efficiency of primary cells, especially mesenchymal stem cells [38], a preliminary study was performed to assess the efficiency of plasmid transfection using a GFP-expressing plasmid and a series of commercially available transfection reagents (see S1 Table and S2 Fig for details of methods, results, and discussion in S2 File). None of the transfection reagents tested provided >2.5% transfection efficiency, which is the minimum required to obtain reliable data with luciferase assays [39]; thus, we did not proceed with the miR-reported gene assay.

Results

Porcine ASC abundance and capacity of differentiation toward the adipogenic lineage

ASC isolated from pigs fed milk tended (P = 0.10) to have a higher amount of ASC isolated per gram of tissue and a higher amount of CFU and ASC proliferation than control pigs (Fig 1A–1C). Isolated ASC successfully differentiated into adipocytes and osteocytes (S3, S4 Figs in S2 File). The latter was observed by the formation of the typical large osteogenic nodules [24]. After adding the adipogenic media, the number of cells presenting lipid droplets (i.e., adipogenesis) significantly increased, but no differences were observed for the proportion of formed adipocytes or lipid accumulation/cells (Fig 1D and 1E).

Fig 1. Effect of milk consumption on adipose stem cells.

Fig 1

(A) number of isolated adipose stem cells (ASC); (B) colony forming unit of ASC; (C) proliferation of ASC; (D) differentiation; and (E) amount of lipid/ASC. ASC were isolated from 6 piglets supplemented with milk and six control piglets supplemented with maltodextrin.

Exosome isolation from porcine plasma and bovine milk

Exosomes isolated from porcine plasma and bovine milk were positive for all measured exosome markers (S5 Fig in S2 File). Furthermore, the transcription of positive and negative markers of mesenchymal cells [40], especially CD90, and CD29, which have been used previously to isolate porcine ASC [41] revealed that the isolated cells have a high expression of CD29, CD90, and STRO-1 and low or no expression of negative markers (S6 Fig in S2 File), supporting positive isolation of ASC. The measurement of exosomes using ZetaView revealed a larger concentration of exosomes in porcine plasma compared to whole bovine milk but only a numerically larger concentration of exosomes isolated from plasma collected from pigs fed with milk compared to plasma from the control pigs (Fig 2A).

Fig 2. Exosomes size distribution in bovine milk and pig plasma.

Fig 2

(A) Abundance, (B) size distribution as diameter shown as continuous, and (C) distribution of diameter shown as incremental (20±10 nm) range of sizes (i.e., bins) of exosomes isolated from the cow’s milk (n = 2) provided to the piglets and from the plasma of the piglets 6–8 hours after consuming either milk (n = 5) or maltodextrin (n = 5; control). *indicates P<0.05 between the percentage of exosomes in the plasma of control- or milk-fed animals.

For the exosome size distribution, the bovine milk had a higher frequency of exosomes in the 40 and 90 nm bins but a lower concentration of exosomes with >90 nm in diameter when compared with plasma (Fig 2B). In addition, the exosomes isolated from the plasma of pigs fed milk had a higher frequency of exosomes in the 80 and 160 nm bins with a tendency for a lower frequency of exosomes in the 120 (P = 0.06) and 140 (P = 0.07) nm bins when compared to exosomes isolated from the plasma of control pigs (Fig 2C).

Porcine ASC mRNA expression

The RNA integrity number (RIN) was 8.9±0.7. There were 508 differentially expressed genes (DEG) with FDR≤0.1 affected by milk supplementation (S3 File and S7 Fig in S2 File). Overall, 236 DEG were down-regulated, and 272 DEG were up-regulated in ASC isolated from pigs supplemented with milk vs. ASC isolated from pigs supplemented with maltodextrin (control).

Dynamic Impact Approach analysis of DEG

The complete results of the DIA analysis are available in S4 File. The summary of KEGG pathways affected by the DEG as analyzed by DIA is reported in Fig 3. The most impacted category of pathways by the DEG between ASC isolated from pig supplemented with milk vs. maltodextrin (control) was the ‘Organismal Systems,’ which was overall inhibited by feeding milk, followed by ‘Metabolism’ (activated) and ‘Environmental Information Processing’ (inhibited). Within the ‘Organismal Systems’ category, many immune-related pathways were inhibited for pigs fed milk vs control. These included pathways related to T cell differentiation and signaling, B cell signaling, and some antigen processing and phagocytosis pathways. The most notable pathways activated within the ‘Metabolism’ category for pigs supplemented with milk included those related to ether lipid metabolism, propanoate metabolism, and glycerophospholipid metabolism. Within the ‘Environmental Information Processing’ category, the VEGF signaling pathway was inhibited in pigs supplemented with milk while the AMPK signaling pathway was activated.

Fig 3. Summary of categories and sub-categories of KEGG pathways from the analysis of differentially expressed genes in adipose stem cells.

Fig 3

Adipose stem cells were isolated from piglets consuming milk (n = 6) or piglets consuming maltodextrin (n = 6; control). The analysis was performed using the Dynamic Impact Approach. Shown are the impact (black horizontal bar; the larger the bar, the larger the impact) and the flux (or direction of the impact; red denotes activation and blue inhibition) of the overall categories of pathways.

The 40 most affected pathways with related categories and sub-categories of pathways (except several sub-categories that are not relevant for ASC, such as digestion and absorption-related pathways, porphyrin and chlorophyll metabolism, addictive substances, and several human diseases) are reported in Fig 4. DIA analysis of the effect of DEG on specific pathways indicated that milk supplementation induced pathways associated with accumulation of lipids (i.e., glycerophospholipid metabolism) and inhibited synthesis of some of the glycans. Pathways inhibited by feeding milk were those associated with signaling, particularly related to VEGF, ErbB, phosphatidylinositol, and MAPK. Milk consumption activated pathways related to hedgehog, notch, and AMPK. Pathways that were inhibited in ASC by feeding milk were most of the immune-related pathways, such as Th cell differentiation, T cell receptor signaling, and antigen processing and presentation. In addition, pathways associated with insulin resistance and type II diabetes were inhibited in ASC from pigs supplemented with milk compared to ASC from the control pigs.

Fig 4. Most impacted KEGG pathways in adipose stem cells by feeding milk to piglets.

Fig 4

The analysis was performed using the Dynamic Impact Approach. Shown are the impact (black horizontal bar; the larger the bar, the larger the impact) and the flux (or direction of the impact; red denotes activation and blue inhibition) of the overall categories of pathways.

DAVID analysis of DEG

The complete results of the DAVID analysis are available in S5 File. A larger number of terms were enriched in down-regulated DEG than up-regulated DEG. In Fig 5 are reported the Gene Ontology Biological Process terms (GO) and KEGG pathways that were enriched with an EASE score<0.05 in both up- and down-regulated DEG. Up-regulated DEG enriched a few GO terms related to several categories; however, of note is the significant enrichment of DEG associated with the negative regulation of insulin signaling. In down-regulated DEG, several pathways related to hormone signaling were enriched, including insulin and growth hormone, as well as pathways associated with the immune system and other signaling pathways. Several of those KEGG pathways were the same as the one revealed to be impacted by DIA.

Fig 5. Gene ontology process affected in adipose stem cells by consumption of milk.

Fig 5

Most enriched Gene Ontology process-related terms and KEGG pathways in up (red bars) and down (blue open bars) differentially expressed transcripts in adipose stem cells (ASC) from piglets supplemented with milk vs. ASC isolated from piglets supplemented with maltodextrin (control). The analysis was performed using DAVID. Horizontal bars denote the significance of enrichment.

Abundance of various miRs in exosomes isolated from bovine milk and porcine plasma

The complete dataset and statistical results of the miRs transcriptome from exosomes isolated from porcine plasma and bovine milk can be found in S6 File. The miRs sequencing in exosomes isolated from plasma generated 5,646,106±3,527,351 reads. Overall, there were 986 miRs (292 annotated to Sus scrofa) in the pig plasma exosomes and 316 (267 annotated to Bos taurus) miRs in the bovine milk exosomes that had at least one average read per million read counts (ARPM; S6 File).

The most abundant miRs in milk exosomes are well-annotated, such as miR-30a, miR30d, miR148a, and miR22 (Fig 6A). Among annotated Sus scrofa miRs, miR-181a, mir-191, and miR92a were the most abundant in plasma exosomes (Fig 6B). However, we identified a large number of novel miRs, where the first eight most abundant miRs (between 62 and 96% of all miRs reads) were all novel with rr437876-1a-3p-miR (1 nt difference with miR183) being extremely abundant, accounting for 74% of all miR reads (Fig 6C).

Fig 6. miRs in bovine milk and porcine plasma.

Fig 6

Most abundant miRs as % of all measured miRs in bovine milk (A) and porcine plasma, both considering porcine-specific miRs (B) and all measured miRs (C). In B, the proportion of all measured miRs is reported. In C, the proportion of all Sus scrofa-specific miRs is reported.

Comparison of miRs isolated from bovine milk vs. miRs isolated from porcine plasma

Our analysis identified 102 orthologous annotated miRs commonly detected in milk and plasma exosomes (S6 File). Most of those were proportionally more abundant (i.e., % of all miRs, P-value<0.05) in plasma obtained from porcine plasma exosomes compared to exosomes isolated from milk (Fig 7). Few miRs were proportionally more abundant in exosomes isolated from milk than those isolated from porcine plasma (Fig 7). Many orthologous miRs were uniquely present in each type of sample, with 138 miRs (57%) uniquely detected in milk. Some of the most abundant miRs in exosomes isolated from milk, such as miR30a and miR30e, were also equally abundant in plasma (Fig 7). In contrast, other abundant miRs were uniquely present in milk exosomes, such as miR200a and miR22 (Fig 8).

Fig 7. miRs common between milk and porcine plasma.

Fig 7

miRs commonly present (as orthologous annotated miRs) in exosomes from bovine milk and porcine plasma. Reported are miRs that were proportionally more abundant (P<0.10) in plasma or milk or with a similar (P>0.1) percentage abundance between plasma and milk exosomes. The difference in % abundance of miRs was analyzed with a t-test between milk (n = 2) and plasma from the plasma of 6 pigs receiving milk.

Fig 8. Unique miRs in milk exosomes.

Fig 8

Thirty most abundant unique annotated miRs in milk exosomes (i.e., not detected in plasma exosomes).

miRs in plasma exosome different between pigs supplemented with milk vs. maltodextrin

Among all miRs detected in porcine plasma exosomes, 38 miRs had a P-value<0.05. Still, only 3 had FDR <0.1 and were more abundant in exosomes isolated from the plasma of pigs fed milk vs. exosomes isolated from the plasma of pigs fed the control diet (Table 1).

Table 1. Porcine plasma exosome miRs with a statistically significant (FDR < 0.1) difference in abundance between pigs fed milk vs. pigs fed maltodextrin (control).

Originalannotation Blast to bovine miRs Milk vs. Control1 P-value FDR In milk exosomes2
rr804814-1a-5p-miR bta-miR-449a 13.0 2.43E-06 0.002 N/D
ssc-miR-194b-5p bta-miR-194b-5p* 5.4 6.00E-05 0.024 N/D
rr1265298-1a-5p-miR not match 29.1 0.00024 0.065 N/D

1fold difference in abundance

2N/D = not detectable

*1 nucleotide difference

The target genes of those miRs are included in S7 File. The combined target genes of all three miRs with a cumulative weighted context++ score of ≤-0.5 were analyzed for the enrichment of biological terms using DAVID (S8 File). The KEGG pathways and gene ontology biological process terms with the most significant enrichment are shown in Table 2. The Wnt pathway and the mitotic cell cycle were among the most enriched gene ontology terms.

Table 2. DAVID enrichment analysis of genes targeted by the three miRs with significantly higher abundance in exosomes isolated from M compared to the exosomes isolated from C.

Shown is the most significant (EASE score<0.05) enriched gene ontology biological process terms and KEGG pathways in targets with a cumulative weighted context++ score of ≤-0.5 with TargetScan.

Term P-value
GO:0017157~regulation of exocytosis 0.001
GO:0034220~ion transmembrane transport 0.004
GO:0007268~chemical synaptic transmission 0.007
GO:0006810~transport 0.011
GO:0045930~negative regulation of mitotic cell cycle 0.014
GO:0010629~negative regulation of gene expression 0.016
GO:0014047~glutamate secretion 0.016
GO:0045608~negative regulation of auditory receptor cell differentiation 0.021
GO:0007386~compartment pattern specification 0.028
GO:0007409~axonogenesis 0.032
GO:0032527~protein exit from endoplasmic reticulum 0.041
GO:0016055~Wnt signaling pathway 0.043
GO:0014807~regulation of somitogenesis 0.048
GO:0042542~response to hydrogen peroxide 0.050
GO:0007269~neurotransmitter secretion 0.050
hsa04721:Synaptic vesicle cycle 0.002
hsa05033:Nicotine addiction 0.040

None of the miRs found in bovine milk exosomes that were commonly (i.e., orthologous) present in bovine milk and porcine plasma were differentially expressed in the plasma exosomes isolated from the piglets supplemented with milk vs. the ones isolated from piglets supplemented with maltodextrin (i.e., control). (S6 File).

Potential target genes of miRs in milk among DEG in ASC

As we identified only three miRs in porcine plasma exosomes that were differentially abundant between pig-fed milk vs. maltodextrin, we performed an additional bioinformatic analysis to determine which miRs could affect the expression of DEG in ASC between the two groups of pigs and which among those could be found in high abundance in milk exosomes. The analysis revealed 459 unique miRs that could have affected the transcription of down-regulated DEG (S9 File). Among those 21 miRs were found in bovine milk including the miR30a and miR30e, the two most abundant miRs in milk exosomes, and miR21 and let7a, abundant in milk exosomes as well (Fig 6A), although all, except 4 (miR9, miR424, miR429, and miR484, all with a relatively low abundance in milk exosomes) were also present in porcine plasma exosomes.

We selected several exosomes to assess the transfer of exosomes from milk to porcine plasma (Table 3). The selection of miRs was based on a prior publication (miR29b and miR200c) [17], high abundance in milk exosomes but undetectability (let7b, miR200a, and miR22) or lower abundance (miR148a) in plasma exosomes, and/or present only in plasma exosomes (miR1285).

Table 3. miRs selection for testing exosome transfer from bovine milk to porcine plasma.

mRNA Abundance in plasma Abundance in milk
CTR Milk P-value
miR-29b 21.9 10.2 0.21 26.4
miR-200c ND ND N/A 287
miR-1285 883 894 0.89 ND
miR-148a 1231 1030 0.92 11,412
let-7b* ND ND N/A 1,134
miR-200a ND ND N/A 3,008
miR-22 ND ND N/A 9,348

*Bta-let-7b corresponds with Scc-let-7c (with one nucleotide difference); the abundance of this was 1648 for CTR and 1355 for Milk

All miRs were detectable using RTqPCR, however, among milk-specific miRs, the detection was particularly good for let7b (contrary to the RNAseq data), while the detection was extremely low for the other miRs, even the ones detected in plasma exosomes using RNAseq (Fig 9). We detected milk bovine-specific transcripts in exosomes isolated from porcine plasma. However, the detection was extremely low (between 100 and >1000 fold lower than in exosomes isolated from bovine milk, Fig 9). The results reveal an increase in abundance of miR22 and miR29b in exosomes isolated from the pig plasma between 4 and 6 hours after milk consumption (Fig 9). No effect was observed for any of the other miRs or the milk-specific mRNAs CSN3 and LALBA.

Fig 9. Assessment of vertical transfer of milk exosomes in circulation of piglets.

Fig 9

Transcription abundance of selected miRs expected to be abundantly or uniquely present in bovine milk exosomes (let7b, miR22, miR48a, miR29b, miR200a and miR200c), miR1285 expected to be present only in porcine plasma exosomes, bovine milk-specific mRNA (CSN3 and LALBA), and a porcine housekeeping gene (GAPDH) present in exosomes isolated from porcine plasma before and during the 6 hours after milk consumption. The P-value of the time effect is reported, and different letters denote significant effect (P<0.05) between the various time points. The range of the Cq (crossing point, a.k.a. cycle to threshold).

Discussion

Milk increases the number but not the adipogenic differentiation of ASC

To our knowledge, this is the first report on the role of milk consumption in ASC. Our data revealed that supplementing milk improved the quantity and proliferative capacity of ASC, although it did not affect their adipogenic differentiation capacity. Obesity is the consequence of an increased proliferation of ASC followed by their differentiation and lipid accumulation in response to a high-energy diet [3, 42]. In young humans, proliferation is the primary way to expand the adipose tissue [42]. An insufficient expansion of adipose tissue can induce ectopic fat accumulation that can trigger inflammation and insulin resistance [42]. The pigs in our experiment were not obese, and there was no difference in back and neck fat accumulation amongst treatment groups [23]. If the increase in proliferation we saw in vitro for pigs consuming milk is also true in vivo, then the increased proliferative capacity of ASC by feeding milk could be beneficial in preventing obesity. To determine if milk could improve the response to obesity, an experiment with a dietary high-energy model should be performed.

Milk affects the transcripts related to inflammation, insulin signaling, and neuronal function in ASC

The effect of milk on the transcriptome of ASC is remarkable given that mesenchymal stem cells, besides affecting the formation of the adipose tissue, can have a broad impact on the body. Mesenchymal stem cells help to mitigate inflammation by interacting with the immune system [43] and participate in regenerating many tissues [44]; thus, a change in the transcriptome of those cells can have long-term and broad consequences. The bioinformatics analysis of the transcriptome revealed that the immune system and various signaling pathways, including insulin signaling, were the most critical functions affected by milk consumption compared with maltodextrin consumption.

In this study, milk supplementation compared with a maltodextrin solution had an anti-inflammatory effect by inhibiting the T cell receptor signaling that plays an essential role in a pro-inflammatory immune response, usually mitigated by mesenchymal stem cells [4547]. Similarly, mesenchymal stem cells can down-regulate FcԐRI signaling in mast cells, resulting in less inflammatory mediators’ production [48]. The FcԐRI signaling pathway in mast cells is associated with the activation of a pro-inflammatory response in the presence of antigens bound to IgE [48]. The FcԐRI signaling was inhibited in the ASC of pigs supplemented with milk compared with a maltodextrin solution. Inflammation is important in the context of obesity because it has been strongly linked to insulin resistance [49, 50]. With the increase in pro-inflammatory cytokine secretion by adipose cells, the expression of insulin receptor substrate and glucose transporter 4 is decreased, inducing insulin resistance [47]. Our data support this link as it reveals an inhibition of insulin resistance in ASC from pigs supplemented milk compared with a maltodextrin solution. Interestingly, milk supplementation also appears to inhibit insulin and growth hormone signaling. This would contrast with the apparent decrease in insulin resistance. One of the central genes down-regulated by milk supplementation on ASC related to insulin signaling is the gene coding for phosphoinositide 3-kinase (PI3K) proteins. The PI3K is a crucial protein in both adipogenesis [51] and osteogenesis [52] of mesenchymal stem cells and plays a central role in insulin signaling where the disruption of the PI3k/AKT signaling is associated with insulin resistance and obesity [53]. Thus, the downregulation of PI3K would suggest that milk consumption would decrease the adipogenesis capacity of ASC, although we did not observe such a phenotype.

One pathway that was not highly impacted by treatment but is still of interest is the tumor necrosis factor (TNF) signaling pathway. The TNF signaling pathway is of interest due to its negative association with adipogenesis and positive association with an obese phenotype [54]. TNFα has been shown to repress Peroxisome Proliferator-Activated Receptor γ (PPARγ), one of the leading transcription factors responsible for adipogenic differentiation [54]. In addition, TNFα and other pro-inflammatory cytokines play a role in dysregulating the cyclic guanosine monophosphate signaling pathway (cGMP) necessary for differentiating ASC [54]. The downregulation of the TNF signaling pathway, along with the upregulation of the cGMP pathway in pigs consuming milk, would suggest increased adipogenesis of the ASC. However, our data only showed a numerically larger quantity of ASC in pigs consuming milk vs. pigs consuming maltodextrin in passage 1 ASC. TNFα is also involved in inducing insulin resistance [55]; thus, a potential decrease of TNFα signaling by the decrease of inflammatory pathways seen in pigs supplemented with milk might benefit insulin sensitivity. A reduction in insulin resistance in ASC in pigs supplemented with milk is also supported by inhibiting the Mitogen-Activated Protein Kinase 1 (MAPK) signaling pathway [56]. Overall, the decrease in inflammatory-related pathways and MAPK supports a potential reduction in insulin resistance and risk of type II diabetes in ASC of pigs consuming milk compared with a maltodextrin solution.

Among neuronal system pathways, neurotrophin signaling was inhibited by milk consumption. This is important because ASC can differentiate into various cell lines, including neurons [57]. This pathway promotes neuronal differentiation along with neuron survival, meaning the down-regulation of this pathway could result in less neuronal differentiation [58]. This is further supported by the putative target genes of the miRs in plasma exosomes that were more abundant in pigs fed milk vs. a control diet. According to the bioinformatics analysis, this inhibition of the neurotrophin signaling pathway in pigs supplemented with milk could negatively affect pathways such as Wnt signaling and cell cycle. The Wnt pathway is important for cell proliferation and differentiation and has been shown to inhibit adipogenesis when overexpressed [56]. The Wnt pathway has also been shown to increase neuronal differentiation when stimulated by neurotrophins [59]. Overall, this data would suggest that the ASC from the control piglets would be more prone to neurogenesis and less prone to adipogenesis when compared to the ASC from the piglets consuming milk. This could have important implications for using mesenchymal stem cells for neuronal disorders/regeneration [60]. In addition, by ASC from pigs consuming milk showing down-regulation of genes associated with the negative regulation of the mitotic cell cycle, we would expect a higher proliferation [61], as we observed.

The ErB signaling and VEGF signaling pathways, both associated with ASC proliferation and differentiation, were inhibited in the ASC of pigs consuming milk [62, 63]. In addition, the Hedgehog pathway, shown to decrease adipogenesis in human ASC, was up-regulated in the same group [64].

It has been previously argued that milk consumption, especially its high protein content, could hyperactivate mTORC1 and cause obesity [7, 21, 65]. In our analysis, the mTOR pathway was not highly impacted and was inhibited overall in ASC isolated from pigs consuming milk (see S4 and S5 Files). Our data contrasts with a previous study conducted in mice by Bar Yamin et al. [66]. In that study, mice fed whole milk had a decrease in AMPK (but an increase in pAMPK), one of the major energy-sensing systems that inhibit mTOR signaling, and a concomitant increase in phosphorylation and nuclear presence of S6K1, a downstream of mTORC1. The nuclear S6K1 can block the expression of WNT genes and, as a consequence, increase adipogenesis and proliferation of ASC by increasing the expression of the two master regulators PPARγ and CEBP/alpha [6770]. In our study, we observed an increased proliferation of ASC from pigs fed with milk; however, we did not observe higher adipogenesis of ASC isolated from pigs fed milk, and the transcription of the various WNT isoforms, PPARG, and CEBPA, was not affected by feeding milk. Furthermore, the pigs fed milk did not accumulate more fat than the control animals [23]. Despite our data not supporting a higher activation of mTOR in ASC response to feeding milk, we cannot exclude that mTOR was affected by feeding milk to pigs. This could be determined by measuring mTOR activation on ASC, which was, however, beyond the scope of our study.

The study by Bar Yamin et al. also noted a decrease in insulin signaling for mice consuming whole milk [66]. This was similar to the results reported by Hoppe et al. [71], where they found an increase in insulin secretion and resistance in children consuming 53g of protein from whole milk compared to a control group. Our bioinformatic analysis suggested down-regulation of insulin resistance-related pathways in ASC of pigs consuming milk compared with those consuming a maltodextrin solution. The differences compared to the prior study are two-fold: 1) our study design had control pigs supplemented with isocaloric maltodextrin, while the studies mentioned above had diets with and without milk; 2) the above studies look into the adipose tissue while we isolated and studied ASC.

For the miRNA, miR-449a and miR-4251, both found in greater abundance in pigs supplemented with milk, have mainly been studied in the context of cancer treatment, with miR-449a regulating proliferation [72]. This contrasts with the increase in proliferation observed in ASC of pigs consuming milk. In addition, miR-194b has been linked to decreased adipogenesis through the deactivation of chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII), essential for mesenchymal stem cell differentiation to adipocytes [73]. Thus, our study does not support those prior observations, as milk consumption did not affect ASC adipogenesis. One possibility for this difference is that plasma exosomal miRs are not acting on the ASC. It has been previously reported that miRNA secreted in microvesicles from ASC can influence differentiation [74]. For our study, we may have observed more differentially expressed miRNA had we isolated miRNA from the subcutaneous adipose tissue in addition to the plasma.

Overall, the differentially expressed pathways in the ASC of pigs supplemented with milk tended to be associated with a down-regulation in inflammation and insulin resistance and an up-regulation in adipogenesis and proliferation. This was at odds with the pathways associated with the more abundant miR isolated from milk-fed porcine plasma and the lack of difference in adipogenesis between the two treatment groups.

miRs from milk are not transferred to circulation

Previous studies have found various miRs to be highly abundant in bovine milk exosomes. These miRs include miR-200c, miR-26a, and miR-148a amongst others [7577]. In this study, the top ten most abundant miRs in milk, including miR30, miR148, miR22, miR191, and miR41, have not previously been reported as highly abundant in bovine milk exosomes [7577]. Of these miRs, miR19, miR30, and miR148 were among the most abundant annotated miRs in pig plasma exosomes. This finding can hinder a proper evaluation of the transfer of miRs from the intestine to circulation (i.e., vertical transfer) due to the high conservation of miRs sequences between species, as previously argued [78].

Several researchers provided data supporting a vertical transfer of bovine milk exosomes (and/or their miRs) affecting peripheral tissues, including the brain [17, 18, 7984]. Recently, vertical transmission of miRs from bovine colostrum in pig plasma using xenomiRs was reported [85]. The vertical transfer of miRs is not without controversy. A reanalysis using microarray and RNA sequencing of miRs from plasma samples collected in humans after milk consumption, where an evident increase of milk-specific miRs was observed [17], failed to confirm the data [86]. It is worth noting that, for that study, samples arrived without dry ice but were evaluated and found not to have signs of degradation. A recent literature review revealed several studies where there was no evidence of uptake of exosomes from milk (or other food) into circulation [87]. Our pig plasma miRs profiles did not support any transfer of bovine milk miRs into the circulation of piglets when blood was collected according to previous study protocols. Based on those findings, we hypothesized that we could have missed the window of uptake of miRs, as the pig’s blood was collected >6 hours after feeding the milk. Oligonucleotides have a relatively short half-life in circulation, and the absorption of several compounds by the intestine is relatively rapid, with a peak during the first 2 hours after a meal [88]. In a human study fed uridine, the peak presence of uridine in blood was during the first 4-hour post-meal [89]. Therefore, we proceeded with the second study to assess if miRs from milk can be vertically transferred into porcine circulation, following methodologies that successfully captured milk miRs vertical transfer in humans [17]. The high abundance of milk-specific mRNA in milk exosomes, such as LALBA and CSN3 [90], and a relatively low identity in the sequence of those mRNA between pigs and bovines (81.5 and 78% identical alignment, respectively) allow for bovine-specific primers to be designed while avoiding confounding effects when measuring the highly conserved miRs [78]. Because of the above, we measured those mRNA to assess the presence of a vertical transfer of exosomes from milk to circulation, as those should be carried with the exosomes as the miRs. We detected those two mRNA but at an extremely low level and with no noticeable increase after milk consumption. Thus, despite our efforts, we could not detect any vertical transfer of miRs or mRNA from bovine milk to porcine circulation. While these findings do not support exosome vertical transfer amongst species, they reveal that miRs are conserved when comparing profiles of pig plasma to cow milk.

So, how can we best explain our findings? Our experiment may have missed the window to capture any milk-derived miRs in pig plasma. Lin et al. [91] detected a peak in milk-specific miRs in porcine plasma between 3 and 6 days of feeding milk but with a level similar to before feeding milk at 12 days. This is relevant, as in our first experiment, we collected blood from the piglets only once at the end of one month of feeding milk. Still, in our second experiment, we collected blood to measure miRs after six days of feeding milk, corresponding to the maximal period of milk-specific miRs detected by Lin et al. [91]. Despite this, we did not detect any miRs.

The portion of our study that explored the vertical transfer of miRs was based on Baier et al. [17] which used adult humans. However, the available studies carried out in piglets by Lin et al. [91] and Weil et al. [85] used neonatal piglets, while we used between 5 and 9-week-old piglets. More recent studies on the vertical transfer of exosomes [82, 83] were performed in nursing mice pups. It has been well-established that the intestine of neonatal mammals is more porous, allowing for the absorption of relatively large proteins until the maturation of the intestinal epithelium, around 6–9 months of age in humans [9294]. In piglets, the intestinal closure is very fast, with most of the closure happening 24 hours post-birth with a complete closure before 6 weeks of age [95], although the uptake of large molecules by the intestinal epithelia is still present after 24h, no significant transfer of those molecules into circulation is observed [96, 97]. The colostrum consumed in the early post-birth stage helps close the intestine to the transfer of large molecules, with a possible preeminent role of extracellular vesicles, including exosomes [98, 99]. Thus, it is possible that the positive vertical transfer of milk miRs observed in the above-cited studies was due to the porous intestine of nursing animals. In contrast, studies in humans, in which a vertical transfer of miRs was observed, were carried out in adults [17, 100]. The milk consumed was relatively large (from 0.25 to 1 L). Large amounts of lactose might not be promptly digested, upsetting the intestine and inducing a leaky gut, where the impaired epithelial barrier allows large particles, such as exosomes, to be transferred [101]. In piglets, weaning stress can compromise intestinal health, affecting the absorption capacity of the intestine and, in worst cases, destroying the intestinal barrier and compromising the growth of the animals [102]. The piglets used in our study were all healthy and had no apparent gastrointestinal issues [23]. Thus, we assumed that the stress of weaning those animals did not compromise their health or, as a consequence, the results of our study. Except for a few instances of loose feces after the introduction of lactose or maltodextrin supplementation [23]. Those were not serious and resolved fast, indicating that the piglets could digest lactose and that no intestinal issues were present in the animals during the study.

Unlike all the above-cited studies where exosome transfer was assessed, we isolated exosomes from the plasma before measuring miRs. In contrast, the other studies measured miRs directly in plasma or serum without isolating exosomes. As there are different types of extracellular cargos [103], it is possible that our isolation excluded vesicles that carried milk-derived miRs. Thus, it is possible that milk-specific miRs detected in circulation in the above studies are not from exosomes but from other vesicles.

Limitations of the study

As determined in our prior paper [23], the accumulation of fat and the distribution of adipocyte size can respond differently to feeding milk between pig breeds. Thus, our findings, especially concerning ASC, might be limited to using the Duroc-Berkshire breed. Using ultracentrifugation only in milk and not in plasma could have confounded the findings. However, the distribution size of exosomes was similar between milk and plasma.

We isolated ASC from the subcutaneous adipose tissue; however, visceral fat can be more relevant for male humans, as fat accumulation is more significant in visceral fat depot than in the subcutaneous adipose tissue [104]. The two fat depots respond differently to insulin, as observed in the Munich MIDY pig model [105]. The ASC from the two depots are very similar in humans, as demonstrated via a whole transcriptomic analysis by Baglioni et al. [106]. Despite this, as the authors of that study also suggested, we recognized that the use of visceral ASC might have been more relevant to be investigated in our study.

Using isocaloric maltodextrin supplementation instead of an isocaloric and isonitrogenous supplementation can be considered a significant limitation considering the role of amino acids, especially branched-chain amino acids, on adipogenesis via mTOR [7]. Even though our data do not suggest an effect of milk consumption on mTOR of ASC, the use of an isonitrogenous, or even better, an amino acids-match control diet, would have allowed us to investigate more clearly the effect of milk. The reason for using only an isocaloric supplement was based on the aim to mimic the “real world” situation where children replace milk consumption with sugar-sweetened beverages, as previously discussed [107].

Conclusions

Our data only partly supported the original hypothesis of the effect of milk on ASC via changing the miRs in exosomes. The milk did affect the ASC, phenotypically and at the transcriptomic level; however, the changes observed were not due to miRs from milk exosomes. This was further supported by the time course study, where we failed to demonstrate a vertical transfer of miRs from milk exosomes to circulation, as initially hypothesized. The transcriptomic data on ASC revealed an effect of milk on decreasing inflammatory-related pathways, insulin signaling, and neuronal-related pathways when compared with consuming a maltodextrin solution. The significance of our findings related to childhood obesity is not completely clear, especially regarding the effect on insulin signaling. Finally, milk contains many bioactive compounds that could have affected the transcriptome of the ASC, including branched-chain amino acids [108110]; however, the investigation of those was beyond the aim of the present research.

Supporting information

S1 File. CellProfiler pipeline used to analyze the number of adipocytes and the content of lipid droplets in the present manuscript.

(CPPROJ)

pone.0302702.s001.cpproj (546.4KB, cpproj)
S2 File. Trough, adipose stem cells (ASC) transfection and differentiation, exosomal markers, and Volcano plot of differentially expressed genes in ASC.

Fig 1. Trough used to provide milk to the piglets; Table 1 and Fig 2. Data and results of the transfection of adipose stem cells with various transfection agents; Figs 3 and 4. Images of the adipose stem cells differentiated in adipocytes and osteocytes; Fig 5. Analysis of exosomal markers from exosomes isolated form milk and plasma of pigs; Fig 6. Transcript abundance of mesenchymal and porcine-specific adipose stem cells markers in ASC; Fig 7. Volcano plot of the DEG in between ASC from pigs supplemented with milk vs. ASC of milk supplemented with isocaloric maltodextrin solution.

(DOCX)

pone.0302702.s002.docx (2.7MB, docx)
S3 File. Complete results of the transcriptome analysis of adipose stem cells.

(XLSX)

pone.0302702.s003.xlsx (15.9MB, xlsx)
S4 File. Details results of KEGG pathway analysis by the Dynamic Impact Approach of the adipose stem cells transcriptome of piglets receive milk or maltodextrin as supplement.

(XLSX)

pone.0302702.s004.xlsx (208KB, xlsx)
S5 File. Details results of the enrichment analysis by DAVID of differentially expressed genes between adipose stem cells of piglets receiving milk vs. adipose stem cells of piglets receiving maltodextrin as a supplement.

(XLSX)

pone.0302702.s005.xlsx (186.1KB, xlsx)
S6 File. Overall results of miRNA analysis of bovine milk and porcine plasma and statistical results of the comparison of the miRNA between exosomes isolated from piglets fed milk vs. piglets fed maltodextrin.

(XLSX)

pone.0302702.s006.xlsx (967.6KB, xlsx)
S7 File. Targets of miRNA that were differently abundant in exosomes isolated from piglets fed milk vs. piglets fed maltodextrin.

(XLSX)

pone.0302702.s007.xlsx (595.3KB, xlsx)
S8 File. Enrichment analysis of functions by DAVID of target genes of the miRNA that were differently abundant in exosomes isolated from piglets fed milk vs. piglets fed maltodextrin.

(XLSX)

pone.0302702.s008.xlsx (26.3KB, xlsx)
S9 File. miRNA targeting genes that were differentially expressed in adipose stem cells isolated from piglets fed milk vs. adipose stem cells isolated from piglets fed maltodextrin.

(XLSX)

pone.0302702.s009.xlsx (322.8KB, xlsx)

Acknowledgments

The authors thank the following students for their help during the experiment: Heaven Roberts, Sarah Akers, Cassie Penix, Emily Sahagun, Randi Wilson, Tamay Guevara, Minda Newhouse, Katie White, Eric Tam, Catalina Tello, Enrique Perez, Kaitlyn Vander Pas, Nina Enos, Emilie Peterson, Nicolas Rivero, Winnie Luo, Nicolas Aguilera, and Sebastiano Busato for their help with feeding the piglets and sample collection.

Data Availability

RNAseq files are available from the Sequence Read Archive (NCBI) database (accession number(s) PRJNA1083710).

Funding Statement

USDA National Institute of Food and Agriculture (Washington, DC) Agriculture and Food Research Initiative Exploratory, grant # 2015-67030-23872, along with the National Needs Graduate Fellowships, Grant #2014-38420-21800 The funders had no role in study design, data collection, and analysis, the decision to publish, or preparation of the manuscript.

References

  • 1.Allcock DM, Gardner MJ, Sowers JR. Relation between Childhood Obesity and Adult Cardiovascular Risk. International journal of pediatric endocrinology. 2009;2009:108187–. Epub 2009/10/19. doi: 10.1155/2009/108187 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Cawthorn WP, Scheller EL, MacDougald OA. Adipose tissue stem cells meet preadipocyte commitment: going back to the future. J Lipid Res. 2012;53(2):227–46. Epub 2011/12/06. doi: 10.1194/jlr.R021089 ; PubMed Central PMCID: PMC3269153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Tang QQ, Lane MD. Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem. 2012;81:715–36. Epub 2012/04/03. doi: 10.1146/annurev-biochem-052110-115718 . [DOI] [PubMed] [Google Scholar]
  • 4.Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome—an allostatic perspective. Biochim Biophys Acta. 2010;1801(3):338–49. Epub 2010/01/09. doi: 10.1016/j.bbalip.2009.12.006 . [DOI] [PubMed] [Google Scholar]
  • 5.Xu S, Xue Y. Pediatric obesity: Causes, symptoms, prevention and treatment. Exp Ther Med. 2016;11(1):15–20. Epub 2016/02/03. doi: 10.3892/etm.2015.2853 ; PubMed Central PMCID: PMC4726862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Niculescu MD. Nutritional epigenetics. Ilar j. 2012;53(3–4):270–8. Epub 2013/06/08. doi: 10.1093/ilar.53.3-4.270 . [DOI] [PubMed] [Google Scholar]
  • 7.Melnik BC. Excessive Leucine-mTORC1-Signalling of Cow Milk-Based Infant Formula: The Missing Link to Understand Early Childhood Obesity. Journal of obesity. 2012;2012:197653-. Epub 2012/03/19. doi: 10.1155/2012/197653 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Vanderhout SM, Birken CS, Parkin PC, Lebovic G, Chen Y, O’Connor DL, et al. Relation between milk-fat percentage, vitamin D, and BMI z score in early childhood. Am J Clin Nutr. 2016;104(6):1657–64. Epub 2016/11/18. doi: 10.3945/ajcn.116.139675 . [DOI] [PubMed] [Google Scholar]
  • 9.Beck AL, Heyman M, Chao C, Wojcicki J. Full fat milk consumption protects against severe childhood obesity in Latinos. Prev Med Rep. 2017;8:1–5. Epub 2017/09/01. doi: 10.1016/j.pmedr.2017.07.005 ; PubMed Central PMCID: PMC5552381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Keller A, Bucher Della Torre S. Sugar-Sweetened Beverages and Obesity among Children and Adolescents: A Review of Systematic Literature Reviews. Child Obes. 2015;11(4):338–46. Epub 2015/08/11. doi: 10.1089/chi.2014.0117 ; PubMed Central PMCID: PMC4529053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Albala C, Ebbeling CB, Cifuentes M, Lera L, Bustos N, Ludwig DS. Effects of replacing the habitual consumption of sugar-sweetened beverages with milk in Chilean children. Am J Clin Nutr. 2008;88(3):605–11. Epub 2008/09/10. doi: 10.1093/ajcn/88.3.605 ; PubMed Central PMCID: PMC2583441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Papandreou D, Andreou E, Heraclides A, Rousso I. Is beverage intake related to overweight and obesity in school children? Hippokratia. 2013;17(1):42–6. . [PMC free article] [PubMed] [Google Scholar]
  • 13.Donnet-Hughes A, Duc N, Serrant P, Vidal K, Schiffrin EJ. Bioactive molecules in milk and their role in health and disease: the role of transforming growth factor-beta. Immunol Cell Biol. 2000;78(1):74–9. Epub 2000/01/29. doi: 10.1046/j.1440-1711.2000.00882.x . [DOI] [PubMed] [Google Scholar]
  • 14.Ha M, Kim VN. Regulation of microRNA biogenesis. Nature Reviews Molecular Cell Biology. 2014;15(8):509–24. doi: 10.1038/nrm3838 [DOI] [PubMed] [Google Scholar]
  • 15.Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem. 2010;285(23):17442–52. Epub 2010/04/01. doi: 10.1074/jbc.M110.107821 ; PubMed Central PMCID: PMC2878508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Izumi H, Kosaka N, Shimizu T, Sekine K, Ochiya T, Takase M. Bovine milk contains microRNA and messenger RNA that are stable under degradative conditions. J Dairy Sci. 2012;95(9):4831–41. Epub 2012/08/25. doi: 10.3168/jds.2012-5489 . [DOI] [PubMed] [Google Scholar]
  • 17.Baier SR, Nguyen C, Xie F, Wood JR, Zempleni J. MicroRNAs are absorbed in biologically meaningful amounts from nutritionally relevant doses of cow milk and affect gene expression in peripheral blood mononuclear cells, HEK-293 kidney cell cultures, and mouse livers. J Nutr. 2014;144(10):1495–500. Epub 2014/08/15. doi: 10.3945/jn.114.196436 ; PubMed Central PMCID: PMC4162473 conflicts of interest. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zempleni J. Chapter 12—MicroRNAs and exosomes in human milk. In: McGuire MK, O’connor Dl, editors. Human Milk: Academic Press; 2021. p. 337–56. [Google Scholar]
  • 19.Kosaka N, Izumi H, Sekine K, Ochiya T. microRNA as a new immune-regulatory agent in breast milk. Silence. 2010;1(1):7. doi: 10.1186/1758-907X-1-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Mercado C, Eades G, Zhou Q. MicroRNAs: A New Class of Master Regulators of Adipogenesis. Human Genetics & Embryology. 2013;3(2). doi: 10.4172/2161-0436.1000108 [DOI] [Google Scholar]
  • 21.Melnik BC, John SM, Schmitz G. Milk is not just food but most likely a genetic transfection system activating mTORC1 signaling for postnatal growth. Nutr J. 2013;12:103. Epub 2013/07/26. doi: 10.1186/1475-2891-12-103 ; PubMed Central PMCID: PMC3725179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fisher KD, Scheffler TL, Kasten SC, Reinholt BM, van Eyk GR, Escobar J, et al. Energy Dense, Protein Restricted Diet Increases Adiposity and Perturbs Metabolism in Young, Genetically Lean Pigs. PLOS ONE. 2013;8(8):e72320. doi: 10.1371/journal.pone.0072320 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Swanson K, Kutzler M, Bionaz M. Cow milk does not affect adiposity in growing piglets as a model for children. J Dairy Sci. 2019;102(6):4798–807. Epub 2019/03/25. doi: 10.3168/jds.2018-15201 . [DOI] [PubMed] [Google Scholar]
  • 24.Monaco E, Sobreira de Lima A, Bionaz M, Maki A, Wilson S, Hurley W, et al. Morphological and Transcriptomic Comparison of Adipose and Bone Marrow Derived Porcine Stem Cells. The Open Tissue Engineering and Regenerative Medicine Journal. 2009;2:20–33. doi: 10.2174/1875043500902010020 [DOI] [Google Scholar]
  • 25.Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;11. doi: 10.1186/gb-2006-7-10-r100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Bionaz M, Loor JJ. Identification of reference genes for quantitative real-time PCR in the bovine mammary gland during the lactation cycle. Physiol Genomics. 2007;29(3):312–9. Epub 2007/02/08. doi: 10.1152/physiolgenomics.00223.2006 . [DOI] [PubMed] [Google Scholar]
  • 27.Bray NL, Pimentel H, Melsted P, Pachter L. Near-optimal probabilistic RNA-seq quantification. Nature Biotechnology. 2016;34(5):525–7. doi: 10.1038/nbt.3519 [DOI] [PubMed] [Google Scholar]
  • 28.Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnetjournal. 2011;17(1):10–2. doi: 10.14806/ej.17.1.200 [DOI] [Google Scholar]
  • 29.Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biology. 2009;10(3):R25. doi: 10.1186/gb-2009-10-3-r25 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011;39(Database issue):D152–7. Epub 2010/11/03. doi: 10.1093/nar/gkq1027 ; PubMed Central PMCID: PMC3013655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Bell J, Larson M, Kutzler M, Bionaz M, Lohr CV, Hendrix D. miRWoods: Enhanced precursor detection and stacked random forests for the sensitive detection of microRNAs. PLoS Comput Biol. 2019;15(10):e1007309. Epub 2019/10/10. doi: 10.1371/journal.pcbi.1007309 ; PubMed Central PMCID: PMC6785219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Tramontana S, Bionaz M, Sharma A, Graugnard DE, Cutler EA, Ajmone-Marsan P, et al. Internal controls for quantitative polymerase chain reaction of swine mammary glands during pregnancy and lactation. J Dairy Sci. 2008;91(8):3057–66. doi: 10.3168/jds.2008-1164 . [DOI] [PubMed] [Google Scholar]
  • 33.Ruijter JM, Ramakers C, Hoogaars WMH, Karlen Y, Bakker O, van den Hoff MJB, et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res. 2009;37(6):e45-e. Epub 2009/02/22. doi: 10.1093/nar/gkp045 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols. 2009;4(1):44–57. doi: 10.1038/nprot.2008.211 [DOI] [PubMed] [Google Scholar]
  • 35.Mudunuri U, Che A, Yi M, Stephens RM. bioDBnet: the biological database network. Bioinformatics. 2009;25(4):555–6. Epub 2009/01/07. doi: 10.1093/bioinformatics/btn654 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4. Epub 2015/08/13. doi: 10.7554/eLife.05005 ; PubMed Central PMCID: PMC4532895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Licursi V, Conte F, Fiscon G, Paci P. MIENTURNET: an interactive web tool for microRNA-target enrichment and network-based analysis. BMC Bioinformatics. 2019;20(1):545. Epub 20191104. doi: 10.1186/s12859-019-3105-x ; PubMed Central PMCID: PMC6829817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Park E, Cho HB, Takimoto K. Effective gene delivery into adipose-derived stem cells: transfection of cells in suspension with the use of a nuclear localization signal peptide-conjugated polyethylenimine. Cytotherapy. 2015;17(5):536–42. Epub 20150121. doi: 10.1016/j.jcyt.2014.11.008 . [DOI] [PubMed] [Google Scholar]
  • 39.Osorio JS, Bionaz M. Plasmid transfection in bovine cells: Optimization using a realtime monitoring of green fluorescent protein and effect on gene reporter assay. Gene. 2017;626:200–8. doi: 10.1016/j.gene.2017.05.025 [DOI] [PubMed] [Google Scholar]
  • 40.Mildmay-White A, Khan W. Cell Surface Markers on Adipose-Derived Stem Cells: A Systematic Review. Curr Stem Cell Res Ther. 2017;12(6):484–92. doi: 10.2174/1574888X11666160429122133 . [DOI] [PubMed] [Google Scholar]
  • 41.Garcia GA, Oliveira RG, Dariolli R, Rudge MVC, Barbosa AMP, Floriano JF, et al. Isolation and characterization of farm pig adipose tissue-derived mesenchymal stromal/stem cells. Braz J Med Biol Res. 2022;55:e12343. Epub 20221202. doi: 10.1590/1414-431X2022e12343 ; PubMed Central PMCID: PMC9728630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Shin S, El-Sabbagh AS, Lukas BE, Tanneberger SJ, Jiang Y. Adipose stem cells in obesity: challenges and opportunities. Biosci Rep. 2020;40(6). Epub 2020/05/27. doi: 10.1042/bsr20194076 ; PubMed Central PMCID: PMC7284323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Al-Ghadban S, Bunnell BA. Adipose Tissue-Derived Stem Cells: Immunomodulatory Effects and Therapeutic Potential. Physiology (Bethesda). 2020;35(2):125–33. doi: 10.1152/physiol.00021.2019 . [DOI] [PubMed] [Google Scholar]
  • 44.Vasanthan J, Gurusamy N, Rajasingh S, Sigamani V, Kirankumar S, Thomas EL, et al. Role of Human Mesenchymal Stem Cells in Regenerative Therapy. Cells. 2020;10(1). Epub 2021/01/06. doi: 10.3390/cells10010054 ; PubMed Central PMCID: PMC7823630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Leto Barone AA, Khalifian S, Lee WPA, Brandacher G. Immunomodulatory Effects of Adipose-Derived Stem Cells: Fact or Fiction? BioMed Research International. 2013;2013:383685. doi: 10.1155/2013/383685 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Zhu Y, Feng X. Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus. Stem Cell Research & Therapy. 2018;9(1):149. doi: 10.1186/s13287-018-0898-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Gustafson B, Gogg S, Hedjazifar S, Jenndahl L, Hammarstedt A, Smith U. Inflammation and impaired adipogenesis in hypertrophic obesity in man. American Journal of Physiology-Endocrinology and Metabolism. 2009;297(5):E999–E1003. doi: 10.1152/ajpendo.00377.2009 . [DOI] [PubMed] [Google Scholar]
  • 48.Kim HS, Yun JW, Shin TH, Lee SH, Lee BC, Yu KR, et al. Human Umbilical Cord Blood Mesenchymal Stem Cell-Derived PGE2 and TGF-β1 Alleviate Atopic Dermatitis by Reducing Mast Cell Degranulation. STEM CELLS. 2015;33:1254–66. doi: 10.1002/stem.1913 [DOI] [PubMed] [Google Scholar]
  • 49.Gustafson B, Hedjazifar S, Gogg S, Hammarstedt A, Smith U. Insulin resistance and impaired adipogenesis. Trends Endocrinol Metab. 2015;26:193–200. doi: 10.1016/j.tem.2015.01.006 [DOI] [PubMed] [Google Scholar]
  • 50.Landgraf K, Rockstroh D, Wagner IV, Weise S, Tauscher R, Schwartze JT, et al. Evidence of Early Alterations in Adipose Tissue Biology and Function and Its Association With Obesity-Related Inflammation and Insulin Resistance in Children. Diabetes. 2015;64:1249–61. doi: 10.2337/db14-0744 [DOI] [PubMed] [Google Scholar]
  • 51.Liu X, Li Z, Liu H, Zhu Y, Xia D, Wang S, et al. Flufenamic Acid Inhibits Adipogenic Differentiation of Mesenchymal Stem Cells by Antagonizing the PI3K/AKT Signaling Pathway. Stem Cells Int. 2020;2020:1540905. Epub 20200316. doi: 10.1155/2020/1540905 ; PubMed Central PMCID: PMC7102471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Gao S, Chen B, Zhu Z, Du C, Zou J, Yang Y, et al. PI3K-Akt signaling regulates BMP2-induced osteogenic differentiation of mesenchymal stem cells (MSCs): A transcriptomic landscape analysis. Stem Cell Research. 2023;66:103010. doi: 10.1016/j.scr.2022.103010 [DOI] [PubMed] [Google Scholar]
  • 53.Huang X, Liu G, Guo J, Su Z. The PI3K/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 2018;14(11):1483–96. Epub 20180806. doi: 10.7150/ijbs.27173 ; PubMed Central PMCID: PMC6158718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Sanyal A, Naumann J, Hoffmann LS, Chabowska-Kita A, Ehrlund A, Schlitzer A, et al. Interplay between Obesity-Induced Inflammation and cGMP Signaling in White Adipose Tissue. Cell Rep. 2017;18:225–36. doi: 10.1016/j.celrep.2016.12.028 [DOI] [PubMed] [Google Scholar]
  • 55.Tilg H, Moschen AR. Inflammatory Mechanisms in the Regulation of Insulin Resistance. Molecular Medicine. 2008;14(3):222–31. doi: 10.2119/2007-00119.Tilg [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Bashan N, Dorfman K, Tarnovscki T, Harman-Boehm I, Liberty IF, Blüher M, et al. Mitogen-Activated Protein Kinases, Inhibitory-κB Kinase, and Insulin Signaling in Human Omental Versus Subcutaneous Adipose Tissue in Obesity. Endocrinology. 2007;148:2955–62. doi: 10.1210/en.2006-1369 [DOI] [PubMed] [Google Scholar]
  • 57.Moore TJ, Abrahamse H. Neuronal Differentiation of Adipose Derived Stem Cells: Progress So Far. 2014. [Google Scholar]
  • 58.Lim JY, Park SI, Oh JH, Kim SM, Jeong CH, Jun JA, et al. Brain-derived neurotrophic factor stimulates the neural differentiation of human umbilical cord blood-derived mesenchymal stem cells and survival of differentiated cells through MAPK/ERK and PI3K/Akt-dependent signaling pathways. J Neurosci Res. 2008;86:2168–78. doi: 10.1002/jnr.21669 [DOI] [PubMed] [Google Scholar]
  • 59.Chen BY, Wang X, Wang ZY, Wang YZ, Chen LW, Luo ZJ. Brain‐derived neurotrophic factor stimulates proliferation and differentiation of neural stem cells, possibly by triggering the Wnt/β‐catenin signaling pathway. J Neurosci Res. 2012;91:30–41. doi: 10.1002/jnr.23138 [DOI] [PubMed] [Google Scholar]
  • 60.Andrzejewska A, Dabrowska S, Lukomska B, Janowski M. Mesenchymal Stem Cells for Neurological Disorders. Adv Sci (Weinh). 2021;8(7):2002944. Epub 20210224. doi: 10.1002/advs.202002944 ; PubMed Central PMCID: PMC8024997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Muruganandan S, Roman AA, Sinal CJ. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: Cross talk with the osteoblastogenic program 66:18. 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Chen G, Shi X, Sun C, Li M, Zhou Q, Zhang C, et al. VEGF-Mediated Proliferation of Human Adipose Tissue-Derived Stem Cells. 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Scioli MG, Bielli A, Gentile P, Mazzaglia D, Cervelli V, Orlandi A. The Biomolecular Basis of Adipogenic Differentiation of Adipose-Derived Stem Cells. Int J Mol Sci. 2014;15:6517–26. doi: 10.3390/ijms15046517 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Fontaine C, Cousin W, Plaisant M, Dani C, Peraldi P. Hedgehog Signaling Alters Adipocyte Maturation of Human Mesenchymal Stem Cells. STEM CELLS. 2008;26:1037–46. doi: 10.1634/stemcells.2007-0974 [DOI] [PubMed] [Google Scholar]
  • 65.Melnik BC. Lifetime Impact of Cow’s Milk on Overactivation of mTORC1: From Fetal to Childhood Overgrowth, Acne, Diabetes, Cancers, and Neurodegeneration. Biomolecules. 2021;11(3). Epub 20210309. doi: 10.3390/biom11030404 ; PubMed Central PMCID: PMC8000710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Bar Yamin H, Barnea M, Genzer Y, Chapnik N, Froy O. Long-term commercial cow’s milk consumption and its effects on metabolic parameters associated with obesity in young mice. Mol Nutr Food Res. 2014;58(5):1061–8. Epub 20131223. doi: 10.1002/mnfr.201300650 . [DOI] [PubMed] [Google Scholar]
  • 67.Yi Sang A, Um Sung H, Lee J, Yoo Ji H, Bang So Y, Park Eun K, et al. S6K1 Phosphorylation of H2B Mediates EZH2 Trimethylation of H3: A Determinant of Early Adipogenesis. Molecular Cell. 2016;62(3):443–52. doi: 10.1016/j.molcel.2016.03.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.de Winter TJJ, Nusse R. Running Against the Wnt: How Wnt/β-Catenin Suppresses Adipogenesis. Front Cell Dev Biol. 2021;9:627429. Epub 20210209. doi: 10.3389/fcell.2021.627429 ; PubMed Central PMCID: PMC7900430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, et al. Inhibition of adipogenesis by Wnt signaling. Science. 2000;289(5481):950–3. doi: 10.1126/science.289.5481.950 . [DOI] [PubMed] [Google Scholar]
  • 70.D’Alimonte I, Lannutti A, Pipino C, Di Tomo P, Pierdomenico L, Cianci E, et al. Wnt signaling behaves as a "master regulator" in the osteogenic and adipogenic commitment of human amniotic fluid mesenchymal stem cells. Stem Cell Rev Rep. 2013;9(5):642–54. doi: 10.1007/s12015-013-9436-5 ; PubMed Central PMCID: PMC3785124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Hoppe C, Mølgaard C, Vaag A, Barkholt V, Michaelsen KF. High intakes of milk, but not meat, increase s-insulin and insulin resistance in 8-year-old boys. Eur J Clin Nutr. 2005;59(3):393–8. doi: 10.1038/sj.ejcn.1602086 . [DOI] [PubMed] [Google Scholar]
  • 72.Niu M, Gao D, Wen Q, Wei P, Pan S, Shuai C, et al. MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma. BMC Cancer. 2016;16. doi: 10.1186/s12885-016-2253-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Jeong BC, Kang IH, Hwang YC, Kim SH, Koh JT. MicroRNA-194 reciprocally stimulates osteogenesis and inhibits adipogenesis via regulating COUP-TFII expression. Cell Death Dis. 2014;5:e1532–e1532. doi: 10.1038/cddis.2014.485 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Arderiu G, Civit-Urgell A, Díez-Caballero A, Moscatiello F, Ballesta C, Badimon L. Differentiation of Adipose Tissue Mesenchymal Stem Cells into Endothelial Cells Depends on Fat Depot Conditions: Regulation by miRNA. Cells. 2024;13(6). Epub 20240314. doi: 10.3390/cells13060513 ; PubMed Central PMCID: PMC10969675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Chen X, Gao C, Li H, Huang L, Sun Q, Dong Y, et al. Identification and characterization of microRNAs in raw milk during different periods of lactation, commercial fluid, and powdered milk products. Cell Res. 2010;20:1128–37. doi: 10.1038/cr.2010.80 [DOI] [PubMed] [Google Scholar]
  • 76.Li R, Dudemaine PL, Zhao X, Lei C, Ibeagha-Awemu EM. Comparative analysis of the miRNome of bovine milk fat, whey and cells. PloS One. 2016;11:e0154129. doi: 10.1371/journal.pone.0154129 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Golan-Gerstl R, Shiff YE, Moshayoff V, Schecter D, Leshkowitz D, Reif S. Characterization and biological function of milk-derived miRNAs. Mol Nutr Food Res. 2017;61:n/a-n/a. doi: 10.1002/mnfr.201700009 [DOI] [PubMed] [Google Scholar]
  • 78.Fromm B, Tosar JP, Lu Y, Halushka MK, Witwer KW. Human and Cow Have Identical miR-21-5p and miR-30a-5p Sequences, Which Are Likely Unsuited to Study Dietary Uptake from Cow Milk. J Nutr. 2018;148(9):1506–7. doi: 10.1093/jn/nxy144 . [DOI] [PubMed] [Google Scholar]
  • 79.Wolf T, Baier SR, Zempleni J. The Intestinal Transport of Bovine Milk Exosomes Is Mediated by Endocytosis in Human Colon Carcinoma Caco-2 Cells and Rat Small Intestinal IEC-6 Cells. J Nutr. 2015;145:2201–6. doi: 10.3945/jn.115.218586 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Zempleni J. Milk exosomes: beyond dietary microRNAs. Genes Nutr. 2017;12. doi: 10.1186/s12263-017-0562-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Feng X, Chen X, Zheng X, Zhu H, Qi Q, Liu S, et al. Latest Trend of Milk Derived Exosomes: Cargos, Functions, and Applications. Front Nutr. 2021;8:747294. Epub 20211029. doi: 10.3389/fnut.2021.747294 ; PubMed Central PMCID: PMC8589029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Manca S, Upadhyaya B, Mutai E, Desaulniers AT, Cederberg RA, White BR, et al. Milk exosomes are bioavailable and distinct microRNA cargos have unique tissue distribution patterns. Scientific Reports. 2018;8(1):11321. doi: 10.1038/s41598-018-29780-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Zhou F, Ebea P, Mutai E, Wang H, Sukreet S, Navazesh S, et al. Small Extracellular Vesicles in Milk Cross the Blood-Brain Barrier in Murine Cerebral Cortex Endothelial Cells and Promote Dendritic Complexity in the Hippocampus and Brain Function in C57BL/6J Mice. Frontiers in Nutrition. 2022;9. doi: 10.3389/fnut.2022.838543 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Betker JL, Angle BM, Graner MW, Anchordoquy TJ. The Potential of Exosomes From Cow Milk for Oral Delivery. J Pharm Sci. 2019;108(4):1496–505. Epub 20181120. doi: 10.1016/j.xphs.2018.11.022 ; PubMed Central PMCID: PMC6788294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Weil PP, Reincke S, Hirsch CA, Giachero F, Aydin M, Scholz J, et al. Uncovering the gastrointestinal passage, intestinal epithelial cellular uptake, and AGO2 loading of milk miRNAs in neonates using xenomiRs as tracers. Am J Clin Nutr. 2023;117(6):1195–210. Epub 20230322. doi: 10.1016/j.ajcnut.2023.03.016 . [DOI] [PubMed] [Google Scholar]
  • 86.Auerbach A, Vyas G, Li A, Halushka M, Witwer K. Uptake of dietary milk miRNAs by adult humans: a validation study. F1000Res. 2016;5:721. Epub 20160422. doi: 10.12688/f1000research.8548.1 ; PubMed Central PMCID: PMC4857747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Martino E, D’Onofrio N, Balestrieri A, Colloca A, Anastasio C, Sardu C, et al. Dietary Epigenetic Modulators: Unravelling the Still-Controversial Benefits of miRNAs in Nutrition and Disease. Nutrients. 2024;16(1). Epub 20240103. doi: 10.3390/nu16010160 ; PubMed Central PMCID: PMC10780859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Rérat A, Giusi-Périer A, Vaissade P. Absorption balances and kinetics of nutrients and bacterial metabolites in conscious pigs after intake of maltose- or maltitol-rich diets. J Anim Sci. 1993;71(9):2473–88. doi: 10.2527/1993.7192473x . [DOI] [PubMed] [Google Scholar]
  • 89.Weinberg ME, Roman MC, Jacob P, Wen M, Cheung P, Walker UA, et al. Enhanced uridine bioavailability following administration of a triacetyluridine-rich nutritional supplement. PLoS One. 2011;6(2):e14709. Epub 20110217. doi: 10.1371/journal.pone.0014709 ; PubMed Central PMCID: PMC3040752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Izumi H, Tsuda M, Sato Y, Kosaka N, Ochiya T, Iwamoto H, et al. Bovine milk exosomes contain microRNA and mRNA and are taken up by human macrophages. J Dairy Sci. 2015;98:2920–33. doi: 10.3168/jds.2014-9076 [DOI] [PubMed] [Google Scholar]
  • 91.Lin D, Chen T, Xie M, Li M, Zeng B, Sun R, et al. Oral Administration of Bovine and Porcine Milk Exosome Alter miRNAs Profiles in Piglet Serum. Scientific Reports. 2020;10(1):6983. doi: 10.1038/s41598-020-63485-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Ellis ZM, Tan HSG, Embleton ND, Sangild PT, van Elburg RM. Milk feed osmolality and adverse events in newborn infants and animals: a systematic review. Arch Dis Child Fetal Neonatal Ed. 2019;104(3):F333–f40. Epub 20181206. doi: 10.1136/archdischild-2018-315946 ; PubMed Central PMCID: PMC6764252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Shulman RJ, Schanler RJ, Lau C, Heitkemper M, Ou CN, Smith EO. Early feeding, feeding tolerance, and lactase activity in preterm infants. J Pediatr. 1998;133(5):645–9. doi: 10.1016/s0022-3476(98)70105-2 . [DOI] [PubMed] [Google Scholar]
  • 94.Siljander H, Jason E, Ruohtula T, Selvenius J, Koivusaari K, Salonen M, et al. Effect of Early Feeding on Intestinal Permeability and Inflammation Markers in Infants with Genetic Susceptibility to Type 1 Diabetes: A Randomized Clinical Trial. J Pediatr. 2021;238:305–11.e3. Epub 20210720. doi: 10.1016/j.jpeds.2021.07.042 . [DOI] [PubMed] [Google Scholar]
  • 95.Ekström GM, Weström BR, Telemo E, Karlsson BW. The uptake of fluorescein-conjugated dextran 70,000 by the small intestinal epithelium of the young rat and pig in relation to macromolecular transmission into the blood. J Dev Physiol. 1988;10(3):227–33. . [PubMed] [Google Scholar]
  • 96.Ekström GM, Weström BR. Cathepsin B and D activities in intestinal mucosa during postnatal development in pigs. Relation to intestinal uptake and transmission of macromolecules. Biol Neonate. 1991;59(5):314–21. doi: 10.1159/000243365 . [DOI] [PubMed] [Google Scholar]
  • 97.Clarke RM, Hardy RN. Histological changes in the small intestine of the young pig and their relation to macromolecular uptake. J Anat. 1971;108(Pt 1):63–77. ; PubMed Central PMCID: PMC1234227. [PMC free article] [PubMed] [Google Scholar]
  • 98.Aarts J, Boleij A, Pieters BCH, Feitsma AL, van Neerven RJJ, Ten Klooster JP, et al. Flood Control: How Milk-Derived Extracellular Vesicles Can Help to Improve the Intestinal Barrier Function and Break the Gut-Joint Axis in Rheumatoid Arthritis. Front Immunol. 2021;12:703277. Epub 20210728. doi: 10.3389/fimmu.2021.703277 ; PubMed Central PMCID: PMC8356634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Melnik BC, Stremmel W, Weiskirchen R, John SM, Schmitz G. Exosome-Derived MicroRNAs of Human Milk and Their Effects on Infant Health and Development. Biomolecules. 2021;11(6). Epub 20210607. doi: 10.3390/biom11060851 ; PubMed Central PMCID: PMC8228670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Wang L, Sadri M, Giraud D, Zempleni J. RNase H2-Dependent Polymerase Chain Reaction and Elimination of Confounders in Sample Collection, Storage, and Analysis Strengthen Evidence That microRNAs in Bovine Milk Are Bioavailable in Humans. J Nutr. 2018;148(1):153–9. doi: 10.1093/jn/nxx024 ; PubMed Central PMCID: PMC6251634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71(5):1020–32. Epub 20220201. doi: 10.1136/gutjnl-2021-326789 ; PubMed Central PMCID: PMC8995832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Tang X, Xiong K, Fang R, Li M. Weaning stress and intestinal health of piglets: A review. Front Immunol. 2022;13:1042778. Epub 20221124. doi: 10.3389/fimmu.2022.1042778 ; PubMed Central PMCID: PMC9730250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Raposo G, Stoorvogel W. Extracellular vesicles: Exosomes, microvesicles, and friends. Journal of Cell Biology. 2013;200(4):373–83. doi: 10.1083/jcb.201211138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Chang E, Varghese M, Singer K. Gender and Sex Differences in Adipose Tissue. Curr Diab Rep. 2018;18(9):69. Epub 20180730. doi: 10.1007/s11892-018-1031-3 ; PubMed Central PMCID: PMC6525964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Flenkenthaler F, Ländström E, Shashikadze B, Backman M, Blutke A, Philippou-Massier J, et al. Differential Effects of Insulin-Deficient Diabetes Mellitus on Visceral vs. Subcutaneous Adipose Tissue—Multi-omics Insights From the Munich MIDY Pig Model. Frontiers in Medicine. 2021;8. doi: 10.3389/fmed.2021.751277 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Baglioni S, Francalanci M, Squecco R, Lombardi A, Cantini G, Angeli R, et al. Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue. Faseb j. 2009;23(10):3494–505. Epub 20090707. doi: 10.1096/fj.08-126946 . [DOI] [PubMed] [Google Scholar]
  • 107.Batty B, Kutzler M, Campbell S, Turner R, Bionaz M. Effect of milk vs. sugar-sweetened beverage supplementation on bone development in pre-pubertal pigs as model for children. Italian Journal of Animal Science. 2020;19(1):1329–40. doi: 10.1080/1828051X.2020.1816508 [DOI] [Google Scholar]
  • 108.Pan J, Chen M, Li N, Han R, Yang Y, Zheng N, et al. Bioactive Functions of Lipids in the Milk Fat Globule Membrane: A Comprehensive Review. Foods. 2023;12(20). Epub 20231012. doi: 10.3390/foods12203755 ; PubMed Central PMCID: PMC10606317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Nielsen SD, Liang N, Rathish H, Kim BJ, Lueangsakulthai J, Koh J, et al. Bioactive milk peptides: an updated comprehensive overview and database. Crit Rev Food Sci Nutr. 2023:1–20. Epub 20230728. doi: 10.1080/10408398.2023.2240396 ; PubMed Central PMCID: PMC10822030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Korhonen HJ. Bioactive Components in Bovine Milk. Bioactive Components in Milk and Dairy Products 2009. p. 13–42. [Google Scholar]

Decision Letter 0

Wilfried A Kues

7 May 2024

PONE-D-24-14376Bovine Milk Consumption Affects the Transcriptome of Porcine Adipose Stem Cells: do Exosomes Play any Role?PLOS ONE

Dear Dr. BIONAZ,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.Please find below the reviews of two experts in the field, which both recommended improvements to make the manuscript publication-ready.

Please submit your revised manuscript by Jun 21 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Wilfried A. Kues, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Acknowledgments Section of your manuscript:

"This work was supported by the USDA National Institute of Food and Agriculture (Washington, DC) Agriculture and Food Research Initiative Exploratory, grant # 2015-67030-23872 to MB, DH, and MK, along with the National Needs Graduate Fellowships, Grant #2014-38420-21800 (MB was among the co-PI and supported the PhD of KS). "

We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

 "USDA National Institute of Food and Agriculture (Washington, DC) Agriculture and Food Research Initiative Exploratory, grant # 2015-67030-23872, along with the National Needs Graduate Fellowships, Grant #2014-38420-21800"

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. Thank you for stating the following financial disclosure:

"USDA National Institute of Food and Agriculture (Washington, DC) Agriculture and Food Research Initiative Exploratory, grant # 2015-67030-23872, along with the National Needs Graduate Fellowships, Grant #2014-38420-21800"          

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.  

Before we proceed with your manuscript, please address the following prompts:

   a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

   b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see

https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

We will update your Data Availability statement on your behalf to reflect the information you provide.

5. Please amend your authorship list in your manuscript file to include author "Michelle Kutzler".

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. The abstract is not fully described, the background is not sufficient to support the current study, and the important research objectives and significance are missing. Please rewrite.

2. Introduction (lines 43-51): The focus of your study is not highlighted, so it is suggested to describe the function of ASC in detail.

3. Introduction (lines 52-62): The logic is unclear, so it is suggested to organize the logical structure.

4. Lines 65-69: The reference citations are not standardized, [11,12] appear twice in consecutive sentences.

5. Lines 80-82: You have not detected the expression of miRs in ASC and have not analyzed the transfer of miRs in exosomes in ASC, so how did you arrive at this conclusion? It is suggested to supplement experimental data on the transfer of miRs in exosomes in ASC.

6. Line 180: The reference format is incorrect.

7. Line 361: Fig. 1A and B have no significant differences, so it is suggested to describe the three indicators separately in detail.

8. Line 369: Exosomes? should be described in detail for the title.

9. Line 388-394: The description of Fig. 3 is too brief and lacks important results.

10. Line 410-420: The up-regulated and down-regulated genes are not found in Fig. 5, did the author miss labeling them?

11. Fig. 7 and Fig. 9 lack a number for each result.

12. Line 495-498: No results for body weight are found, how did the conclusions come about?

13. Line 515: What is FcԐRI signaling?

14. Line 594-596: Reference [77] has already explained that there is no evidence to suggest that exosomes from milk are taken up and enter the bloodstream. Why do you detect the transfer of exosomes in plasma and suggest referencing relevant literature and supplementary experiments to explain this?

15. Line 616-646: Please carefully check the citation format of references.

16. The entire discussion section lacks clarity in its logical structure. It is strongly recommended that the author rewrites the discussion section, paying attention to the logical structure, properly cites references, and fully discusses the results of their own research.

Reviewer #2: 1- As noted in both MISEV2018 and MISEV2023 guidelines as well as many other scientific reports, using the exosome term should be limited to experiments that have shown biogenesis of exosomes routed from MVB. Therefore, based on the methodology of this manuscript it is the wrong term. Since the others have only shown size distribution, they cannot even use extracellular vesicle term either. The identity of what has been administered to cells should be clearly investigated and proper terms should be used. Based on MISEV guidelines, marker expression and morphology should be checked.

2- The manuscript is full of language mistakes which made reading difficult and maybe impossible. For example, “Exosomes are around 100 nm in diameter microvesicles that work... “

3- The rationality of the work is not strong. Old references were used and many sentences don’t have proper references.

4- The titles in the method part were very weird. For example, exosome isolation is under “Animals and experimental design”

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Dec 20;19(12):e0302702. doi: 10.1371/journal.pone.0302702.r002

Author response to Decision Letter 0


22 Jul 2024

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

AU: we checked, and the format should be correct.

2. Thank you for stating the following in the Acknowledgments Section of your manuscript:

"This work was supported by the USDA National Institute of Food and Agriculture (Washington, DC) Agriculture and Food Research Initiative Exploratory, grant # 2015-67030-23872 to MB, DH, and MK, along with the National Needs Graduate Fellowships, Grant #2014-38420-21800 (MB was among the co-PI and supported the PhD of KS). "

We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"USDA National Institute of Food and Agriculture (Washington, DC) Agriculture and Food Research Initiative Exploratory, grant # 2015-67030-23872, along with the National Needs Graduate Fellowships, Grant #2014-38420-21800"

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Authors: We remove the references to the grant agencies as indicated.

3. Thank you for stating the following financial disclosure:

"USDA National Institute of Food and Agriculture (Washington, DC) Agriculture and Food Research Initiative Exploratory, grant # 2015-67030-23872, along with the National Needs Graduate Fellowships, Grant #2014-38420-21800"

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

AU: added in the cover letter as indicated.

4. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see

https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

We will update your Data Availability statement on your behalf to reflect the information you provide.

AU: we have submitted all the data not previously put in repositories (i.e., RNAseq) into the DANS Data Station Life Sciences. The dataset is under review and should be available soon.

5. Please amend your authorship list in your manuscript file to include author "Michelle Kutzler".

AU: thanks for catching that! Now Michelle has been added.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: No

Not really sure how to reply to this. Seems subjective.

________________________________________

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: Yes

________________________________________

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

________________________________________

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

Please refer to edited manuscript.

________________________________________

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. The abstract is not fully described, the background is not sufficient to support the current study, and the important research objectives and significance are missing. Please rewrite.

AU: The abstract has been edited to clarify the objectives and conclusions

2. Introduction (lines 43-51): The focus of your study is not highlighted, so it is suggested to describe the function of ASC in detail.

AU: The focus of the study is outlined at the end of the introduction. The function of ASC in obesity is described in lines 53-55.

3. Introduction (lines 52-62): The logic is unclear, so it is suggested to organize the logical structure.

AU: The paragraph has been reorganized for clarity

4. Lines 65-69: The reference citations are not standardized, [11,12] appear twice in consecutive sentences.

AU: This is due to both studies being referenced in both sentences

5. Lines 80-82: You have not detected the expression of miRs in ASC and have not analyzed the transfer of miRs in exosomes in ASC, so how did you arrive at this conclusion? It is suggested to supplement experimental data on the transfer of miRs in exosomes in ASC.

AU: We have modified the sentence to address this point. However, we did not analyze the miRs in ASC. This would have been a good idea….In any case, based on the “vertical transfer” hypothesis we should detect an effect on the cell transcriptome.

6. Line 180: The reference format is incorrect.

AU: Thanks for catching it! Now it is addressed.

7. Line 361: Fig. 1A and B have no significant differences, so it is suggested to describe the three indicators separately in detail.

AU: We are not sure about this comment. The Figures 1A had a tendency while the Figure 1B was significant.

8. Line 369: Exosomes? should be described in detail for the title.

AU: Edited in text

9. Line 388-394: The description of Fig. 3 is too brief and lacks important results.

AU: Edited in text to further elaborate on Fig. 3.

10. Line 410-420: The up-regulated and down-regulated genes are not found in Fig. 5, did the author miss labeling them?

AU: The legend should provide the necessary explanation, as those are not up-and down-regulated genes but are the GO terms from the analysis of up- and down-regulated DEG. We checked the legend for Figure 5 and appeared to be clear.

11. Fig. 7 and Fig. 9 lack a number for each result.

AU: Each figure has a title that indicates the parameter shown. The legend should provide further details. We can add letters to indicate each figure, if needed, but it appears to increase the complexity of the figure rather than helping.

12. Line 495-498: No results for body weight are found, how did the conclusions come about?

AU: Body weight was reported in a previous paper referenced in the beginning of the methods section.

13. Line 515: What is FcԐRI signaling?

AU: This pathway is now further described in the text.

14. Line 594-596: Reference [77] has already explained that there is no evidence to suggest that exosomes from milk are taken up and enter the bloodstream. Why do you detect the transfer of exosomes in plasma and suggest referencing relevant literature and supplementary experiments to explain this?

AU: Our study did not detect the transfer of exosomes. We sought to further explain changes in the ASC transcriptome by determining whether vertical transfer of exosomes is possible, but our data do not support that theory.

15. Line 616-646: Please carefully check the citation format of references.

AU: Any errors in citation format have been fixed.

16. The entire discussion section lacks clarity in its logical structure. It is strongly recommended that the author rewrites the discussion section, paying attention to the logical structure, properly cites references, and fully discusses the results of their own research.

AU: We have edited the text to improve the logical flow of the discussion and remove unnecessary information. We have also fixed all citations.

Reviewer #2: 1- As noted in both MISEV2018 and MISEV2023 guidelines as well as many other scientific reports, using the exosome term should be limited to experiments that have shown biogenesis of exosomes routed from MVB. Therefore, based on the methodology of this manuscript it is the wrong term. Since the others have only shown size distribution, they cannot even use extracellular vesicle term either. The identity of what has been administered to cells should be clearly investigated and proper terms should be used. Based on MISEV guidelines, marker expression and morphology should be checked.

AU: Additional work has been added to show confirmation of exosomes markers. This has been added to the methods and results.

2- The manuscript is full of language mistakes which made reading difficult and maybe impossible. For example, “Exosomes are around 100 nm in diameter microvesicles that work... “

AU: The manuscript has been edited to make reading easier.

3- The rationality of the work is not strong. Old references were used and many sentences don’t have proper references.

AU: The manuscript has been edited. We have checked the references, and they all appear proper.

4- The titles in the method part were very weird. For example, exosome isolation is under “Animals and experimental design”

AU: Titles have been clarified in the manuscript.

Decision Letter 1

Wilfried A Kues

23 Aug 2024

PONE-D-24-14376R1Bovine Milk Consumption Affects the Transcriptome of Porcine Adipose Stem Cells: do Exosomes Play any Role?PLOS ONE

Dear Dr. BIONAZ,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please have a close look on the points brought up by to experts in the field (below).

Please submit your revised manuscript by Oct 07 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Wilfried A. Kues, Ph.D.

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #3: All comments have been addressed

Reviewer #4: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #3: Yes

Reviewer #4: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: Yes

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: This paper present enough data, which may be interesting to readers. I think this ms had been well revised according to comments of reviewers. I deem it is acceptable, though it is of the following mean concerns or limitations:

1. If sEV were separated from bovine milk, and then used in the trail, results would be more convincible. As we know, milk contains more bioactive components other than sEV.

2. The conclusive idea, that miRs from milk are not transferred to circulation, is confuse. Reasons for this include: you have detected changes of ASC in piglets received bovine milk; miR29 and 22 were significantly increased in pig 3 6 hours after feeding milk(fig 9). Thus I suggest to change this conclusive idea.

By the way, the minor notices:

1.“CO2” is not correct.

2. I suggest to add more discussion on the absorption mechanism of digestive tract on milk sEV and its cargo miR or mRNA.

3. according to ISEV guideline, exosome should be replaced with sEV, small extracellular vesicle.

Reviewer #4: Review manuscript no. PONE-D-24-14376

Bovine Milk Consumption Affects the Transcriptome of Porcine Adipose Stem Cells: Do

Exosomes Play any Role?

Katherine Swanson, Jimmy Bell, David Hendrix, Duo Jiang, Brandon Batty, Melanie

Hanlon and Massimo Bionaz

General comment

The investigators studied the nutrigenomic effects of cow´s milk consumption on

the transcriptome of adipocyte stem cells (ASCs) of porcine subcutaneous adipose tissue after the piglet´s lactation period, with special attention to bovine milk exosomal microRNAs (miRs).

In detail: ASCs isolated from 19-20 week old piglets supplemented for 11 weeks with 750 mL of raw whole cow´s milk tended (P=0.10) to have a higher amount of ASCs isolated per gram of subcutaneous adipose tissue and a higher amount of CFU and ASC proliferation than control piglets fed an isocaloric protein-free maltodextrin solution.

Over 500 genes were differentially expressed (DEG) in ASCs isolated from bovine milk-fed vs. maltodextrin-fed control piglets. Bioinformatic analysis of DEG indicated an inhibition of the immune, neuronal, and endocrine systems and insulin-related pathways in ASCs of milk-fed piglets. Surprisingly, bioinformatic data point to an inhibition of the mTOR pathway in ASCs isolated from piglets consuming milk despite increased ASC proliferation. Experimental direct determination such as pS6K1 expression – as a measure of mTORC1 activity – have not been presented.

The investigators did not detect any exosomal miR or mRNA transfer from bovine milk to porcine-circulating plasma exosomes when investigating three 5-week-old Yorkshire Hampshire piglets implying that milk´s nutrigenomic effect on ASCs is not attributed to miRs in milk exosomes as observed after the lactation period.

The key message of the study is that cow´s milk consumption increased ASC numbers and ASC proliferation. However, the biological contribution of milk exosomal miRs on the epigenetic regulation of ASCs during lactation before and after weaning remains controversial and requires further investigations.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: Yes: Yongliang Zhang

Reviewer #4: Yes: Bodo C. Melnik

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Review 23.08.24.docx

pone.0302702.s010.docx (37.8KB, docx)
PLoS One. 2024 Dec 20;19(12):e0302702. doi: 10.1371/journal.pone.0302702.r004

Author response to Decision Letter 1


20 Nov 2024

The authors thank the reviewers for their time and insights. Please find our responses below.

Review Comments to the Author

Reviewer #3: This paper present enough data, which may be interesting to readers. I think this ms had been well revised according to comments of reviewers. I deem it is acceptable, though it is of the following mean concerns or limitations:

1. If sEV were separated from bovine milk, and then used in the trail, results would be more convincible. As we know, milk contains more bioactive components other than sEV.

AU: The authors acknowledge that milk contains bioactive compounds that could also contribute to the results seen in this study. However, the overall objective of the study was to explore any differences in circulating miR and their effect on ASC transcriptome in pigs consuming milk compared with pigs consuming a maltodextrin solution. We have added one sentence in the conclusion to address this point.

2. The conclusive idea, that miRs from milk are not transferred to circulation, is confuse. Reasons for this include: you have detected changes of ASC in piglets received bovine milk; miR29 and 22 were significantly increased in pig 3 6 hours after feeding milk(fig 9). Thus I suggest to change this conclusive idea.

AU: Our data clearly shows no uptake of any miRNA in the blood of pigs. The change in miRNA in blood was not related to the milk miRNA. We do not know what affects those two miRNAs, but the effect was due to some other components in milk rather than miRNA vertically transferred from milk to circulation.

By the way, the minor notices:

1.“CO2” is not correct.

AU: Revised in manuscript

2. I suggest to add more discussion on the absorption mechanism of digestive tract on milk sEV and its cargo miR or mRNA.

AU: At this time, there is no known mechanism of absorption, just speculation

3. according to ISEV guideline, exosome should be replaced with sEV, small extracellular vesicle. https://www.isev.org/misev

AU: we checked on the isev web site but we could not find such a note. Rather, the isev indicated that exosomes are part of sEV.

Reviewer #4: Review manuscript no. PONE-D-24-14376

General comment

The investigators studied the nutrigenomic effects of cow´s milk consumption on

the transcriptome of adipocyte stem cells (ASCs) of porcine subcutaneous adipose tissue after the piglet´s lactation period, with special attention to bovine milk exosomal microRNAs (miRs).

In detail: ASCs isolated from 19-20 week old piglets supplemented for 11 weeks with 750 mL of raw whole cow´s milk tended (P=0.10) to have a higher amount of ASCs isolated per gram of subcutaneous adipose tissue and a higher amount of CFU and ASC proliferation than control piglets fed an isocaloric protein-free maltodextrin solution.

Over 500 genes were differentially expressed (DEG) in ASCs isolated from bovine milk-fed vs. maltodextrin-fed control piglets. Bioinformatic analysis of DEG indicated an inhibition of the immune, neuronal, and endocrine systems and insulin-related pathways in ASCs of milk-fed piglets. Surprisingly, bioinformatic data point to an inhibition of the mTOR pathway in ASCs isolated from piglets consuming milk despite increased ASC proliferation. Experimental direct determination such as pS6K1 expression – as a measure of mTORC1 activity – have not been presented.

The investigators did not detect any exosomal miR or mRNA transfer from bovine milk to porcine-circulating plasma exosomes when investigating three 5-week-old Yorkshire Hampshire piglets implying that milk´s nutrigenomic effect on ASCs is not attributed to miRs in milk exosomes as observed after the lactation period.

The key message of the study is that cow´s milk consumption increased ASC numbers and ASC proliferation. However, the biological contribution of milk exosomal miRs on the epigenetic regulation of ASCs during lactation before and after weaning remains controversial and requires further investigations.

AU: We thank the reviewer for thoroughly reviewing our manuscript and for the many suggestions and references provided!

Specific comments

Major flaws regarding the study design

The selected time period

To assess the impact of cow´s milk on adipocyte stem cell (ASC) proliferation in the porcine system, the physiology of porcine lactation and weaning has to be matched more closely. The nursing time of domestic pigs is 3-4 weeks, whereas wild pigs provide milk up to 16 weeks.

The study started with piglets 8- to 9 weeks of age exposed to cow´s milk for a further 11 weeks. Thus, the study may have missed a critical early window of postnatal milk-exosome-controlled ASC proliferation.

AU: For our study, we sought to use piglets as a model for young children, not infants. Therefore, we chose older weaned piglets that would consume milk supplementally, not as their primary form of nutrition.

Selected animals and postnatal time periods

The reviewer wonders why the investigators used Duroc-Berkshire male piglets 8-9 weeks of age (n=6) for their milk challenge experiment but 5-week-old Yorkshire Hampshire piglets (n=3) for their exosome miR studies. Thus, the genetic background of the animals, the number of studied animals and timing of the sampling differ substantially, an avoidable mismatch for the later translation of obtained results.

Nevertheless, the use of 5 week old piglets may have compromised intestinal milk exosome and miR uptake and miR transmission into the circulatory system during this late stage of lactation (differences of colostrum milk exosomes versus mature milk exosomes). Differences in intestinal permeability and exosome composition and quantity have to be considered.

In 3–6 days old human neonates, intestinal permeability decreases in both term and preterm neonates.

van Elburg RM, Fetter WP, Bunkers CM, Heymans HS. Intestinal permeability in relation to birth weight and gestational and postnatal age. Arch Dis Child Fetal Neonatal Ed. 2003 Jan;88(1):F52-5. doi: 10.1136/fn.88.1.f52. PMID: 12496227; PMCID: PMC1755997.

Frazer LC, Good M. Intestinal epithelium in early life. Mucosal Immunol. 2022 Jun;15(6):1181-1187. doi: 10.1038/s41385-022-00579-8. Epub 2022 Nov 15. PMID: 36380094; PMCID: PMC10329854.

According to literature data, the intestinal closure in the piglet, i.e. the dramatic decrease in the transfer of macromolecules from the intestinal epithelium in the blood, is at about 24 h of age.

Ekström GM, Weström BR. Cathepsin B and D activities in intestinal mucosa during postnatal development in pigs. Relation to intestinal uptake and transmission of macromolecules. Biol Neonate. 1991;59(5):314-21. doi: 10.1159/000243365. PMID: 1714775.

Clarke RM, Hardy RN. Histological changes in the small intestine of the young pig and their relation to macromolecular uptake. J Anat. 1971 Jan;108(Pt 1):63-77. PMID: 5543214; PMCID: PMC1234227.

Ekström GM, Weström BR, Telemo E, Karlsson BW. The uptake of fluorescein-conjugated dextran 70,000 by the small intestinal epithelium of the young rat and pig in relation to macromolecular transmission into the blood. J Dev Physiol. 1988 Jun;10(3):227-33. PMID: 2464019.

Colostrum exosome transfer during the first hours and days of postnatal life may have already stabilized the intestinal permeability barrier limiting later transfer of mature milk exosomes.

Aarts J, Boleij A, Pieters BCH, Feitsma AL, van Neerven RJJ, Ten Klooster JP, M'Rabet L, Arntz OJ, Koenders MI, van de Loo FAJ. Flood Control: How Milk-Derived Extracellular Vesicles Can Help to Improve the Intestinal Barrier Function and Break the Gut-Joint Axis in Rheumatoid Arthritis. Front Immunol. 2021 Jul 28;12:703277. doi: 10.3389/fimmu.2021.703277. PMID: 34394100; PMCID: PMC8356634.

Tong L, Zhang S, Liu Q, Huang C, Hao H, Tan MS, Yu X, Lou CKL, Huang R, Zhang Z, Liu T, Gong P, Ng CH, Muthiah M, Pastorin G, Wacker MG, Chen X, Storm G, Lee CN, Zhang L, Yi H, Wang JW. Milk-derived extracellular vesicles protect intestinal barrier integrity in the gut-liver axis. Sci Adv. 2023 Apr 14;9(15):eade5041. doi: 10.1126/sciadv.ade5041. Epub 2023 Apr 12. PMID: 37043568; PMCID: PMC10096581.

Guo MM, Zhang K, Zhang JH. Human Breast Milk-Derived Exosomal miR-148a-3p Protects Against Necrotizing Enterocolitis by Regulating p53 and Sirtuin 1. Inflammation. 2022 Jun;45(3):1254-1268. doi: 10.1007/s10753-021-01618-5. Epub 2022 Jan 29. PMID: 35091894.

Melnik BC, Stremmel W, Weiskirchen R, John SM, Schmitz G. Exosome-Derived MicroRNAs of Human Milk and Their Effects on Infant Health and Development. Biomolecules. 2021 Jun 7;11(6):851. doi: 10.3390/biom11060851. PMID: 34200323; PMCID: PMC8228670.

Samuel M, Chisanga D, Liem M, Keerthikumar S, Anand S, Ang CS, Adda CG, Versteegen E, Jois M, Mathivanan S. Bovine milk-derived exosomes from colostrum are enriched with proteins implicated in immune response and growth. Sci Rep. 2017 Jul 19;7(1):5933. doi: 10.1038/s41598-017-06288-8. PMID: 28725021; PMCID: PMC5517456.

AU: We thank the reviewer for all the suggested references and comments! As indicated above and in our manuscript, we used piglets as models for human children. Thus, using different breeds should not be an issue but a strength, as humans are genetically diverse compared to pig breeds. If the vertical transfer of miRNA in children drinking milk happens, it should be evident by using an animal model with a very similar intestinal anatomy and function to humans. The time course experiment only confirmed what we observed with the main experiment; thus, it appears sufficient to allow us to conclude that if any vertical transfer of miRNA is happening, this would happen at a very low rate, at least less than 30% of the children consuming a very large amount of milk (i.e., did not happen in our 3 piglets). As discussed in our paper, we agree with the reviewer that the exosomes are likely vertically transferred during the nursing phase, while the intestinal permeability is present but becomes insignificant afterward. Our data confirmed such an idea, as argued in the discussion. Although we agree with the reviewer, our original hypothesis was that miRNAs are vertically transferred in children (or post-nursing piglets) and adults, which our data disproved. However, we have added most of the reviewer's suggestions and some of the suggested references to the revised discussion.

Weaning stress

It has recently been emphasized that weaning stress often causes changes in the morphology and function of the small intestine of piglets, disrupts digestion and absorption capacity, destroys intestinal barrier function, and ultimately leads to reduced feed intake, increased diarrhea rate, and growth retardation, a point that may be considered as well as the exosome study falls into this period.

Tang X, Xiong K, Fang R, Li M. Weaning stress and intestinal health of piglets: A review. Front Immunol. 2022 Nov 24;13:1042778. doi: 10.3389/fimmu.2022.1042778. PMID: 36505434; PMCID: PMC9730250.

At present, systematic studies investigating the time course of colostrum/milk exosome uptake from birth (time of colostrum exposure) to later periods of lactation (time of mature milk exposure) are missing. Individuals with inflammatory bowel diseases and leaky gut exhibit increased intestinal permeability, a constellation modifying milk exosome kinetics and uptake.

Michielan A, D'Incà R. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut. Mediators Inflamm. 2015;2015:628157. doi: 10.1155/2015/628157. Epub 2015 Oct 25. PMID: 26582965; PMCID: PMC4637104.

AU: This is an interesting point to consider; however, all piglets in this study were healthy with no signs of gastrointestinal distress before being enrolled in our trial. There were minor instances of diarrhea when first introducing the milk and maltodextrin solution, but that was cleared up before the sampling period. This was discussed in our previous paper (see DOI: 10.3168/jds.2018-15201). We have added a comment to the discussion to address this point.

Significant differences in protein intake during the intervention period

The total protein content of the first porcine colostrum (16.65%) is approximately three times the level in porcine mature milk at the end of lactation (5.83%).

Csapó J, Martin TG, Csapó-Kiss ZS, Házas Z. Protein, fats, vitamin and mineral concentrations in porcine colostrum and milk from parturition to 60 days. Intern Dairy J 1966, 6 (8–9): 881-902; https://doi.org/10.1016/0958-6946(95)00072-0

After weaning pigs are physiologically not exposed to milk proteins and milk protein-derived signaling as well as milk exosomes and their potential miR-regulated gene expression.

During the intervention period of this study, piglets received 750 mL whole cow´s milk/day with 3,6% protein concentration resulting in 27 g milk protein uptake/day.

In comparison to the protein-free maltodextrin control, the milk-group received an additional total milk protein amounts of 2 kg providing substantial intake of essential branched-chain amino acids (BCAA) during the intervention period.

Only balancing the caloric intake between the milk group and the maltodextrin group is an oversimplified approach overlooking critical metabolic and epigenetic effects of BCAA-mTORC1 signaling.

BCAAs, enriched in milk proteins, are key activators of insulin and IGF-1 secretion as well as BCAA-mediated mTORC1 activation.

The authors provide no concrete data on mTORC1 activation such as the expression of the mTORC1 downstream target phosphorylated S6K1 (pS6K1). A Western blot analysis of pS6K1 should be provided to control the real impact of milk intake on mTORC1-S6K1 activation in ASCs.

High mTORC1-S6K1 signaling has been linked to increased adipogenesis by high protein formula feeding of human infants.

Melnik BC. Excessive Leucine-mTORC1-Signalling of Cow Milk-Based Infant Formula: The Missing Link to Understand Early Childhood Obesity. J Obes. 2012;2012:197653. doi: 10.1155/2012/197653. Epub 2012 Mar 19. PMID: 22523661; PMCID: PMC3317169.

Melnik BC. The potential mechanistic link between allergy and obesity development and infant formula feeding. Allergy Asthma Clin Immunol. 2014 Jul 22;10(1):37. doi: 10.1186/1710-1492-10-37. PMID: 25071855; PMCID: PMC4112849.

Exposure of infants to high protein formula is an accepted explanation of pediatrics for increased postnatal adipogenic programming by formula feeding.

Luque V, Closa-Monasterolo R, Escribano J, Ferré N. Early Programming by Protein Intake: The Effect of Protein on Adiposity Development and the Growth and Functionality of Vital Organs. Nutr Metab Insights. 2016 Mar 20;8(Suppl 1):49-56. doi: 10.4137/NMI.S29525. PMID: 27013888; PMCID: PMC4803318.

Haschke F, Grathwohl D, Detzel P, Steenhout P, Wagemans N, Erdmann P. Postnatal High Protein Intake Can Contribute to Accelerated Weight Gain of Infants and Increased Obesity Risk. Nestle Nutr Inst Workshop Ser. 2016;85:101-9. doi: 10.1159/000439492. Epub 2016 Apr 18. PMID: 27088337.

AU: We acknowledged in the manuscript that the increase in protein intake could play a role in the mTORC1 pathway. Our bioinformatic analysis of ASC actually found a slight inhibition of the mTORC1 pathway in pigs consuming milk. We have now further discussed in the manuscript these findings. Since the mTORC1 pathway was not significantly affected by diet in our study, we did not see a need to perform further analysis. Additional support for a lack of mTOR activation was the lack of effect on adiposity (see doi: 10.3168/jds.2018-15201).

mTORC1 activation is required for differentiation of mesenchymal stem cells to ASCs

AU: We did not observe a significant change in the mTOR pathway due to diet in our study.

Of note, activated mTORC1 plays a central role in the differentiation of mesenchymal stem cells to ASCs.

Xiang X, Zhao J, Xu G, Li Y, Zhang W. mTOR and the differentiation of mesenchymal stem cells. Acta Biochim Biophys Sin (Shanghai). 2011 Jul;43(7):501-10. doi: 10.1093/abbs/gmr041. Epub 2011 Jun 2. PMID: 21642276.

Zhou J, Li D, Wang F. Assessing the function of mTOR in human embryonic stem cells. Methods Mol Biol. 2012;821:361-72. doi: 10.1007/978-1-61779-430-8_23.

Decision Letter 2

Wilfried A Kues

3 Dec 2024

Bovine Milk Consumption Affects the Transcriptome of Porcine Adipose Stem Cells: do Exosomes Play any Role?

PONE-D-24-14376R2

Dear Dr. BIONAZ,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Wilfried A. Kues, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #3: All comments have been addressed

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: Yes

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: I think authors have tried best to revise this ms. Since this paper present a negative retults compared to the idea that cow milk sEV may regulate recipient via miRNA, it may be helpful in further understanding how cow milk sEV functions in recipeints. Thus, I suggest it be accepted.

Reviewer #4: The revised version of the manuscript improved substantially. The authors answered all major issues raised by the reviewers and provided an updated reference list of the literature. The reviewer has no further comments.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

Reviewer #4: No

**********

Acceptance letter

Wilfried A Kues

10 Dec 2024

PONE-D-24-14376R2

PLOS ONE

Dear Dr. Bionaz,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Wilfried A. Kues

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. CellProfiler pipeline used to analyze the number of adipocytes and the content of lipid droplets in the present manuscript.

    (CPPROJ)

    pone.0302702.s001.cpproj (546.4KB, cpproj)
    S2 File. Trough, adipose stem cells (ASC) transfection and differentiation, exosomal markers, and Volcano plot of differentially expressed genes in ASC.

    Fig 1. Trough used to provide milk to the piglets; Table 1 and Fig 2. Data and results of the transfection of adipose stem cells with various transfection agents; Figs 3 and 4. Images of the adipose stem cells differentiated in adipocytes and osteocytes; Fig 5. Analysis of exosomal markers from exosomes isolated form milk and plasma of pigs; Fig 6. Transcript abundance of mesenchymal and porcine-specific adipose stem cells markers in ASC; Fig 7. Volcano plot of the DEG in between ASC from pigs supplemented with milk vs. ASC of milk supplemented with isocaloric maltodextrin solution.

    (DOCX)

    pone.0302702.s002.docx (2.7MB, docx)
    S3 File. Complete results of the transcriptome analysis of adipose stem cells.

    (XLSX)

    pone.0302702.s003.xlsx (15.9MB, xlsx)
    S4 File. Details results of KEGG pathway analysis by the Dynamic Impact Approach of the adipose stem cells transcriptome of piglets receive milk or maltodextrin as supplement.

    (XLSX)

    pone.0302702.s004.xlsx (208KB, xlsx)
    S5 File. Details results of the enrichment analysis by DAVID of differentially expressed genes between adipose stem cells of piglets receiving milk vs. adipose stem cells of piglets receiving maltodextrin as a supplement.

    (XLSX)

    pone.0302702.s005.xlsx (186.1KB, xlsx)
    S6 File. Overall results of miRNA analysis of bovine milk and porcine plasma and statistical results of the comparison of the miRNA between exosomes isolated from piglets fed milk vs. piglets fed maltodextrin.

    (XLSX)

    pone.0302702.s006.xlsx (967.6KB, xlsx)
    S7 File. Targets of miRNA that were differently abundant in exosomes isolated from piglets fed milk vs. piglets fed maltodextrin.

    (XLSX)

    pone.0302702.s007.xlsx (595.3KB, xlsx)
    S8 File. Enrichment analysis of functions by DAVID of target genes of the miRNA that were differently abundant in exosomes isolated from piglets fed milk vs. piglets fed maltodextrin.

    (XLSX)

    pone.0302702.s008.xlsx (26.3KB, xlsx)
    S9 File. miRNA targeting genes that were differentially expressed in adipose stem cells isolated from piglets fed milk vs. adipose stem cells isolated from piglets fed maltodextrin.

    (XLSX)

    pone.0302702.s009.xlsx (322.8KB, xlsx)
    Attachment

    Submitted filename: Review 23.08.24.docx

    pone.0302702.s010.docx (37.8KB, docx)

    Data Availability Statement

    RNAseq files are available from the Sequence Read Archive (NCBI) database (accession number(s) PRJNA1083710).


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES